-
Publication Venue For
-
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403..
133:1548-1559.
2019
-
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study..
133:1762-1765.
2019
-
How I treat refractory chronic graft-versus-host disease..
133:1191-1200.
2019
-
Bad weed: synthetic cannabinoid-associated coagulopathy..
133:902-905.
2019
-
Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics..
133:724-729.
2019
-
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases..
133:754-762.
2019
-
Introduction to a review series on new therapeutics for inherited and acquired bleeding conditions..
133:383-384.
2019
-
Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway.
132:2431-2440.
2018
-
Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway..
132:2431-2440.
2018
-
Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma..
132:2546-2554.
2018
-
Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice..
132:2188-2200.
2018
-
Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas..
132:1495-1506.
2018
-
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery..
132:1737-1749.
2018
-
CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
132:1013-1021.
2018
-
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML..
132:1125-1133.
2018
-
Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia..
132:727-734.
2018
-
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia..
132:717-726.
2018
-
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis..
131:2541-2551.
2018
-
B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation..
131:2967-2977.
2018
-
Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies..
131:2782-2788.
2018
-
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia..
131:2661-2669.
2018
-
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study..
131:2183-2192.
2018
-
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.
131:1704-1711.
2018
-
B-cell targeting in chronic graft-versus-host disease..
131:1399-1405.
2018
-
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML..
131:1415-1424.
2018
-
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia..
131:387-396.
2018
-
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2..
130:2682-2688.
2017
-
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study..
130:2718-2727.
2017
-
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD..
130:2131-2145.
2017
-
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets..
130:1819-1831.
2017
-
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States..
130:1156-1164.
2017
-
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy..
129:2980-2987.
2017
-
Heparin-induced thrombocytopenia..
129:2864-2872.
2017
-
Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis..
129:2161-2171.
2017
-
Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy..
129:2375-2383.
2017
-
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
129:1763-1767.
2017
-
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era..
129:1763-1767.
2017
-
In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia..
129:1680-1684.
2017
-
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation..
129:1548-1556.
2017
-
Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease..
128:2275.
2016
-
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103..
128:2510-2516.
2016
-
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)..
128:1789-1799.
2016
-
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation..
128:1346-1361.
2016
-
Progress toward less toxic conditioning..
128:322-323.
2016
-
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation..
128:297-312.
2016
-
GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo..
127:2723-2731.
2016
-
Antibodies are back for thymic attack in cGVHD..
127:2170-2171.
2016
-
Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay..
127:2346-2354.
2016
-
Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms..
127:1886-1895.
2016
-
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure..
127:1656-1665.
2016
-
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease..
127:810-819.
2016
-
Incidence of Pediatric VTE in Durham County, North Carolina.
126.
2015
-
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma..
126:2284-2290.
2015
-
Platelets promote pulmonary pull of polys..
126:2174-2175.
2015
-
rVWF: treatment finally reaches the modern age..
126:1975-1976.
2015
-
How I treat catastrophic thrombotic syndromes..
126:1285-1293.
2015
-
MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice..
126:1314-1323.
2015
-
Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells..
126:1086-1094.
2015
-
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire..
125:3835-3850.
2015
-
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease..
125:4085-4094.
2015
-
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation..
125:2885-2892.
2015
-
Crucial role for the VWF A1 domain in binding to type IV collagen..
125:2297-2304.
2015
-
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use..
125:2656-2664.
2015
-
A natural choice for hemophilia B..
125:1509-1510.
2015
-
Aberrant B-cell homeostasis in chronic GVHD..
125:1703-1707.
2015
-
Early HSCT corrects the skeleton in MPS..
125:1518-1519.
2015
-
Liberation of ATP secondary to hemolysis is not mutually exclusive of regulated export..
125:1844-1845.
2015
-
Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study..
125:2164-2172.
2015
-
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations..
125:1367-1376.
2015
-
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila..
125:336-345.
2015
-
Autopsy-Proven Venous Thromboembolism (VTE): Incidence and Characteristics of Patients Correlated with Clinical Management Prior to Death.
124.
2014
-
Cerebral Ischemia in Adults with Sickle Cell Disease after First Stroke.
124.
2014
-
Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy.
124.
2014
-
Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia.
124.
2014
-
MEK Inhibitors, Novel Anti-Adhesive Molecules, Reverse Sickle Red Blood Cell Adhesion and Vaso-Occlusion in Vivo.
124.
2014
-
Patent Foramen Ovale in Adult Patients with Sickle Cell Disease and Stroke.
124.
2014
-
Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices.
124.
2014
-
The DOT1L Inhibitor EPZ-5676: Safety and Activity in Relapsed/Refractory Patients with MLL-Rearranged Leukemia.
124.
2014
-
The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications.
124.
2014
-
Venous Thromboembolism (VTE) Surveillance: Incidence, Characteristics, and Initial Treatment of VTE Patients.
124.
2014
-
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures..
124:3692-3698.
2014
-
Preclinical efficacy of MEK inhibition in Nras-mutant AML..
124:3947-3955.
2014
-
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients..
124:2921-2929.
2014
-
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation..
124:2596-2606.
2014
-
Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity..
124:2223-2234.
2014
-
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
124:1915-1925.
2014
-
A nonsense mutation in IKBKB causes combined immunodeficiency..
124:2046-2050.
2014
-
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma..
124:1915-1925.
2014
-
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes..
124:1473-1480.
2014
-
How I treat sinusoidal obstruction syndrome..
123:4023-4026.
2014
-
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans..
123:3988-3998.
2014
-
Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.
123:3316-3326.
2014
-
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells..
123:2988-2996.
2014
-
The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia..
123:2497-2503.
2014
-
Increased BCR responsiveness in B cells from patients with chronic GVHD..
123:2108-2115.
2014
-
The polyphony of BACH2..
123:950.
2014
-
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia..
122:3432-3439.
2013
-
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality..
122:3651-3658.
2013
-
GATA3 risk alleles are associated with ancestral components in Hispanic children with ALL..
122:3385-3387.
2013
-
Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia..
122:2888-2892.
2013
-
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study..
122:2135-2141.
2013
-
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial..
122:1510-1517.
2013
-
Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients..
122:434-442.
2013
-
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia..
121:4854-4860.
2013
-
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy..
121:4821-4831.
2013
-
Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype..
121:4808-4809.
2013
-
Novel diagnostic assays for heparin-induced thrombocytopenia.
121:3727-3732.
2013
-
Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning..
121:3981-3987.
2013
-
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts..
121:4439-4442.
2013
-
Critical role for mouse marginal zone B cells in PF4/heparin antibody production..
121:3484-3492.
2013
-
Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease..
121:3274-3283.
2013
-
High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass..
121:2828-2835.
2013
-
Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function..
121:3135-3146.
2013
-
Genome-wide study of methotrexate clearance replicates SLCO1B1..
121:898-904.
2013
-
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia..
121:752-758.
2013
-
How I treat thrombocytopenia in pregnancy..
121:38-47.
2013
-
MDS: unraveling the mystery..
120:4906-4908.
2012
-
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans..
120:3635-3646.
2012
-
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia..
120:4197-4204.
2012
-
Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome..
120:4599-4608.
2012
-
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways..
120:2529-2536.
2012
-
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans..
120:1961-1962.
2012
-
Further examination of BAFF SNPs in cGVHD..
120:700-701.
2012
-
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4..
120:181-189.
2012
-
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI..
119:5285-5293.
2012
-
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning..
119:4133-4141.
2012
-
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure..
119:3684-3690.
2012
-
Regulation of mast cell survival and function by tuberous sclerosis complex 1..
119:3306-3314.
2012
-
Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production..
119:2368-2375.
2012
-
Control of GVHD: it's in our DNA!.
119:1102-1103.
2012
-
Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium..
119:1217-1227.
2012
-
Mitochondrial dysfunction in ataxia-telangiectasia..
119:1490-1500.
2012
-
CD62L -
memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.
119:6344-6353.
2012
-
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
120:822-832.
2012
-
Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras..
119:1032-1035.
2012
-
Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A..
119:238-250.
2012
-
Risk factors for acute GVHD and survival after hematopoietic cell transplantation..
119:296-307.
2012
-
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
120:249-258.
2012
-
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category..
118:6920-6929.
2011
-
Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH..
118:5794-5798.
2011
-
LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function..
118:5851-5861.
2011
-
Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia..
118:5914-5917.
2011
-
A2-step approach to myeloablative haploidentical stem cell transplantation: A phase 1/2 trial performed with optimized T-cell dosing.
118:4732-4739.
2011
-
Gene-expression patterns predict phenotypes of immune-mediated thrombosis (Blood (2006) 107, 4, (1391-1396)).
118:4497.
2011
-
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies..
118:4258-4264.
2011
-
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma..
118:4024-4035.
2011
-
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans..
118:3003-3012.
2011
-
Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling..
118:1525-1533.
2011
-
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)..
118:1413-1420.
2011
-
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection..
117:4805-4815.
2011
-
Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence..
117:4142-4153.
2011
-
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice..
117:4590-4599.
2011
-
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new..
117:3268-3276.
2011
-
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse..
117:3294-3301.
2011
-
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations..
117:3641-3647.
2011
-
ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes..
117:2441-2450.
2011
-
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies..
117:2423-2432.
2011
-
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL..
117:1911-1916.
2011
-
Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease..
117:2275-2283.
2011
-
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells..
117:530-541.
2011
-
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: Pretreatment prognostic factors and interim PET.
117:5314-5320.
2011
-
Negative regulation of mTOR activation by diacylglycerol kinases.
117:4022-4031.
2011
-
Regulation of steady-state neutrophil homeostasis by macrophages..
117:618-629.
2011
-
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice.
117:630-637.
2011
-
Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.
116:5679-5687.
2010
-
Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.
116:5679-5687.
2010
-
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia..
116:4958-4967.
2010
-
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study..
116:5660-5669.
2010
-
Heparin modifies the immunogenicity of positively charged proteins..
116:6046-6053.
2010
-
Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation..
116:5518-5527.
2010
-
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation..
116:5111-5118.
2010
-
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer..
116:4045-4059.
2010
-
Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease..
116:3431-3434.
2010
-
microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease..
116:4338-4348.
2010
-
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group..
116:1045-1050.
2010
-
Pulmonary hypertension and nitric oxide depletion in sickle cell disease..
116:687-692.
2010
-
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia..
116:71-80.
2010
-
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission..
116:366-374.
2010
-
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells..
115:5041-5052.
2010
-
Proinflammatory state, hepcidin, and anemia in older persons..
115:3810-3816.
2010
-
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease..
115:3070-3078.
2010
-
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster..
115:1815-1822.
2010
-
Placenta growth factor in sickle cell disease: association with hemolysis and inflammation..
115:2014-2020.
2010
-
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia..
115:1351-1353.
2010
-
Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo.
116:1669-1677.
2010
-
Akt1 and Akt2 promote peripheral B-cell maturation and survival.
115:4043-4050.
2010
-
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
116:3622-3626.
2010
-
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: A Cancer and leukemia group B study.
116:788-792.
2010
-
Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice..
114:5454-5463.
2009
-
Response: Variability in the prevalence of Chlamydophila psittaci infection in patients with OAML.
114:3499-3500.
2009
-
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.
114:1331-1339.
2009
-
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization..
114:1331-1339.
2009
-
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras..
114:1445-1453.
2009
-
Extranodal marginal zone lymphoma of the ocular adnexa..
114:501-510.
2009
-
Type 17 CD8+ T cells display enhanced antitumor immunity..
114:596-599.
2009
-
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma..
113:6069-6076.
2009
-
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma..
113:5720-5726.
2009
-
Patterns of microRNA expression characterize stages of human B-cell differentiation..
113:4586-4594.
2009
-
Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034)..
113:4819-4820.
2009
-
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease..
113:3865-3874.
2009
-
D-dimer antigen: current concepts and future prospects..
113:2878-2887.
2009
-
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes..
113:1768-1777.
2009
-
Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain.
113:4250-4261.
2009
-
A Multicenter, Randomized, Dose Frequency Study of the Safety and Efficacy of Cerezyme (R) Infusions Every 4 Weeks Versus Every 2 Weeks in the Maintenance Therapy of Patients with Type 1 Gaucher Disease.
112:460-460.
2008
-
A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies..
112:350-350.
2008
-
Adherence with Hydroxyurea in Children with Sickle Cell Disease.
112:69-69.
2008
-
Antecedent Transfusion and Primary Hemorrhagic Stroke in Adults with Sickle Cell Disease..
112:512-512.
2008
-
Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity.
112:140-140.
2008
-
Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.
112:1142-1142.
2008
-
Complications of Hysterectomy in Women with Von Willebrand Disease.
112:1166-1166.
2008
-
Development of mPF4/Heparin Antibodies in a Murine Platelet Activation Model.
112:106-107.
2008
-
Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.
112:1118-1118.
2008
-
Does Living Closer to a Medical Care Center Matter in Sickle Cell Disease?.
112:323-324.
2008
-
Early Pre/Post Fluoro-Deoxyglucose Positive Emission Tomography (PET) Does Not Predict Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation in Hodgkins Disease and Non-Hodgkins Lymphoma.
112:760-760.
2008
-
Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome.
112:685-686.
2008
-
Erythrocyte Adhesion and Phosphatidylserine Exposure in HbSC Disease: Baseline Data from the CHAMPS Study..
112:861-861.
2008
-
Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children's Oncology Group Study 1991.
112:9-10.
2008
-
Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL.
112:1078-1078.
2008
-
Functional and Biochemical Changes in Stored Human Red Blood Cells.
112:1355-1355.
2008
-
Gene Expression Profiles with Signatures of Tumor Biology and Chemotherapy Sensitivity May Provide a Novel Approach to Maximize Response to Induction Therapy in Patients with Acute Myeloid Leukemia.
112:785-786.
2008
-
Genomic Approaches to Identifying Risk for Pulmonary Artery Hypertension among Individuals with Sickle Cell Disease..
112:514-514.
2008
-
Identification of Therapeutic Targets for Chronic Lymphocytic Leukemia in the Relapsed and Refractory Setting.
112:720-720.
2008
-
Increased Hepcidin Expression in Mice Affected by beta-Thalassemia Reduces Iron Overload with No Effect on Anemia.
112:53-53.
2008
-
Isolation and Expansion of Oligodendrocytes from Thawed, Cryopreserved Human Umblilical Cord Blood.
112:1193-1193.
2008
-
MicroRNAs Distinguish Burkitt Lymphoma from the Molecular Subsets of Diffuse Large B Cell Lymphoma.
112:1151-1151.
2008
-
MicroRNAs Regulate Mature B Cell Differentiation.
112:262-262.
2008
-
Monocytes Are a Particularly Favorable Target for Surface Platelet Factor 4 (PF4) Antigenic Complex Formation in Heparin-Induced Thrombocytopenia: New Insights into the Thrombotic Risk in HIT.
112:107-107.
2008
-
Obstetric and Gynecological History in Sickle Cell Disease Females.
112:867-868.
2008
-
Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study.
112:250-250.
2008
-
Plasmacytoid CD123+Dendritic Cell Recovery Is An Independent Predictor of Survival after Unrelated Cord Blood Transplant (UCBT).
112:777-777.
2008
-
Prolonged Survival despite High Disease Burden in Elderly (>= 55) Patients with Hb SS or Hb S beta 0 Thalassemia.
112:264-264.
2008
-
Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation.
112:133-134.
2008
-
Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML.
112:1019-1020.
2008
-
Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies..
112:4318-4327.
2008
-
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia..
112:3500-3507.
2008
-
Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes..
112:2979-2989.
2008
-
B lymphocytes: how they develop and function..
112:1570-1580.
2008
-
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia..
112:1993-2003.
2008
-
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia..
112:1005-1012.
2008
-
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines..
112:610-618.
2008
-
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV..
112:1205-1213.
2008
-
Forging a field: the golden age of iron biology..
112:219-230.
2008
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study..
111:5477-5485.
2008
-
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study..
111:5403-5410.
2008
-
Radiologic and nuclear events: contingency planning for hematologists/oncologists..
111:5440-5445.
2008
-
Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study..
111:5515-5523.
2008
-
Development and validation of a predictive model for chemotherapy-associated thrombosis..
111:4902-4907.
2008
-
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia..
111:3991-3997.
2008
-
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group..
111:2984-2990.
2008
-
Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia..
111:2046-2048.
2008
-
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia..
111:1584-1593.
2008
-
IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival..
111:2101-2111.
2008
-
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria..
111:1840-1847.
2008
-
Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase..
111:1497-1503.
2008
-
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.
111:4209-4219.
2008
-
Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells..
111:723-731.
2008
-
Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression.
112:2071-2080.
2008
-
Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5.
112:4905-4914.
2008
-
Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1).
111:209-218.
2008
-
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity..
110:4341-4350.
2007
-
Determinants of PF4/heparin immunogenicity..
110:4253-4260.
2007
-
Risk factors for primary hemorrhagic stroke in adults with sickle cell disease.
110:19B-20B.
2007
-
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1..
110:3706-3714.
2007
-
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)..
110:3526-3531.
2007
-
Are 2 cords better than 1?.
110:2789-2790.
2007
-
Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo..
110:2708-2717.
2007
-
Genetic-based dosing in orthopedic patients beginning warfarin therapy..
110:1511-1515.
2007
-
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)..
110:1713-1722.
2007
-
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201..
110:1105-1111.
2007
-
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study..
110:1388-1396.
2007
-
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)..
110:479-484.
2007
-
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801..
109:5136-5142.
2007
-
Of mice and iron: Ferroportin disease.
109:4115.
2007
-
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511..
109:4164-4167.
2007
-
Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation..
109:4020-4022.
2007
-
Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants..
109:4539-4547.
2007
-
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications..
109:3595-3602.
2007
-
T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex..
109:3198-3206.
2007
-
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse..
109:3115-3123.
2007
-
Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice..
109:2365-2372.
2007
-
The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages..
109:1620-1626.
2007
-
Evidence for an immune barrier after in utero hematopoietic-cell transplantation..
109:1331-1333.
2007
-
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification..
109:1559-1567.
2007
-
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia..
109:896-904.
2007
-
Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm..
109:1381-1386.
2007
-
Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.
109:4038-4044.
2007
-
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
109:5027-5035.
2007
-
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta..
109:619-625.
2007
-
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report..
109:503-506.
2007
-
Treg-cell expansion: Better to be "naive".
108:3963-3964.
2006
-
CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation..
108:4268-4274.
2006
-
Bleeding.Events and other complications during pregnancy and childbirth in women with Von Willebrand disease..
108:302A-302A.
2006
-
Blocking adhesion of sickle erythrocytes to endothelial alpha V beta 3 using RNA aptamer..
108:206A-207A.
2006
-
Genetic polymorphisms associated with priapism in sickle cell disease..
108:236A-237A.
2006
-
Oral forodesine (Bcx-1777) is clinically active in refractory cutaneous T-cell lymphoma: Results of a phase I/II study..
108:698A-698A.
2006
-
Predictors of acute intracranial pathology identified by computerized tomography in children with sickle cell disease..
108:24B-25B.
2006
-
The addition of fludarabine to a conventional Busulfan/Melphalan/Anti-Thymocyte globulin (Flu/Bu/Mel/ATG) preparative regimen increased engraftment without additional toxicity..
108:833A-834A.
2006
-
Cutaneous wound healing is impaired in hemophilia B..
108:3053-3060.
2006
-
Interleukin-6 induces hepcidin expression through STAT3..
108:3204-3209.
2006
-
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26..
108:1602-1610.
2006
-
In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes..
108:1770-1773.
2006
-
Lepirudin: Walking the dosing line.
108:1428-1429.
2006
-
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure..
108:1421-1423.
2006
-
Deferasirox versus deferoxamine..
108:774-775.
2006
-
Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA)..
108:379-381.
2006
-
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes..
107:4491-4499.
2006
-
Role of transforming growth factor-beta in hematologic malignancies..
107:4589-4596.
2006
-
Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications..
107:2346-2353.
2006
-
Gene-expression patterns predict phenotypes of immune-mediated thrombosis..
107:1391-1396.
2006
-
Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice.
107:2952-2958.
2006
-
Improved outcome in CNS aspergillosis, using voriconazole [5].
107:3411-3412.
2006
-
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling..
106:4315-4321.
2005
-
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies..
106:3898-3906.
2005
-
The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment..
106:3854-3859.
2005
-
The immune paradox of fondaparinux.
106:3686-3687.
2005
-
CD molecules 2005: human cell differentiation molecules..
106:3123-3126.
2005
-
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression..
106:2936-2943.
2005
-
Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice..
106:2879-2883.
2005
-
HCT outcomes: A new tool?.
106:2602-2603.
2005
-
Improved outcome in central nervous system aspergillosis, using voriconazole treatment..
106:2641-2645.
2005
-
Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.
106:1552-1558.
2005
-
PF4/heparin complexes are T cell-dependent antigens..
106:929-931.
2005
-
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34..
106:95-102.
2005
-
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222..
105:3420-3427.
2005
-
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand..
105:3206-3213.
2005
-
Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU..
105:3322-3329.
2005
-
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients..
105:886-893.
2005
-
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011..
105:49-53.
2005
-
Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly..
105:161-169.
2005
-
The role of duodenal cytochrome b in intestinal iron absorption remains unclear [2] (multiple letters).
106:4413-4414.
2005
-
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia..
105:131-138.
2005
-
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism..
104:3986-3992.
2004
-
Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions..
104:3774-3781.
2004
-
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome..
104:2783-2790.
2004
-
Your Ad here: optimizing adenoviral vector-based vaccines.
104:2612-2613.
2004
-
A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation..
104:2376-2384.
2004
-
Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome..
104:2574-2581.
2004
-
Quiescent phenotype of tumor-specific CD8+ T cells following immunization..
104:1970-1978.
2004
-
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation..
104:775-780.
2004
-
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS..
104:857-864.
2004
-
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma..
104:642-648.
2004
-
Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia..
104:43-50.
2004
-
Atypical features of familial hemophagocytic lymphohistiocytosis..
103:4610-4612.
2004
-
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia..
103:4036-4042.
2004
-
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation..
103:4344-4352.
2004
-
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder..
103:4243-4250.
2004
-
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells..
103:3986-3988.
2004
-
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation..
103:2009-2018.
2004
-
Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency..
103:1171-1174.
2004
-
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease..
103:1534-1541.
2004
-
Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity..
102:4137-4142.
2003
-
Fatal hepatic necrosis following imatinib mesylate therapy..
102:3455-3456.
2003
-
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin..
102:2574-2580.
2003
-
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis..
102:2364-2372.
2003
-
Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency..
102:2692-2694.
2003
-
Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells..
102:2243-2250.
2003
-
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study..
102:1613-1618.
2003
-
Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders..
102:1869-1871.
2003
-
CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes..
102:1374-1380.
2003
-
Survival of acute myeloid leukemia cells requires PI3 kinase activation..
102:972-980.
2003
-
Synergy between tumor immunotherapy and antiangiogenic therapy..
102:964-971.
2003
-
Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients..
102:1121-1130.
2003
-
S-nitrosohemoglobin is distinguished from other nitrosovasodilators by unique oxygen-dependent responses that support an allosteric mechanism of action..
102:410-411.
2003
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System..
101:5061-5067.
2003
-
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression..
101:4878-4886.
2003
-
Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts..
101:3641-3647.
2003
-
Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia..
101:3106-3108.
2003
-
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk..
101:3008-3013.
2003
-
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion..
101:3281-3287.
2003
-
The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation..
101:2646-2651.
2003
-
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors..
101:1919-1927.
2003
-
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease..
101:2137-2143.
2003
-
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection..
100:4059-4066.
2002
-
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome..
100:4337-4343.
2002
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)..
100:4325-4336.
2002
-
Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells..
100:2662-2664.
2002
-
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes..
100:1602-1610.
2002
-
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells..
100:2159-2167.
2002
-
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720..
100:1224-1232.
2002
-
Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces..
100:539-546.
2002
-
Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo..
100:153-158.
2002
-
FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia..
100:364.
2002
-
Platelet-dependent action of high-dose factor VIIa..
100:364-365.
2002
-
Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis..
99:4400-4405.
2002
-
Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells..
99:4562-4567.
2002
-
Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process..
99:3083-3088.
2002
-
A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis..
99:3066-3069.
2002
-
Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII..
99:2828-2834.
2002
-
The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl..
99:2957-2968.
2002
-
Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation..
99:2235-2240.
2002
-
Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI..
99:1817-1824.
2002
-
Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy..
99:1005-1013.
2002
-
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody..
99:1230-1236.
2002
-
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival..
99:872-878.
2002
-
A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution..
99:364-371.
2002
-
Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease.
100:3776-3781.
2002
-
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy..
99:10-14.
2002
-
Regulation of iron absorption in Hfe mutant mice.
100:1465-1469.
2002
-
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation..
98:3505-3512.
2001
-
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies..
98:3569-3574.
2001
-
Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen..
98:3486-3488.
2001
-
Absolute lymphoid and myeloid dendritic cell counts in umbilical cord blood, bone marrow, and peripheral blood..
98:321B-321B.
2001
-
Alemtuzumab (Campath) in relapsed or refractory CLL or PLL..
98:290B-291B.
2001
-
Binding and uptake of PF4/heparin/antibody complexes in multiple cell types..
98:35A-35A.
2001
-
Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment..
98:104B-104B.
2001
-
Correction of Hurler Syndrome with unrelated umbilical cord blood transplantation..
98:667A-667A.
2001
-
Cytokine modulation of inducible nitric oxide synthase (NOS2) mRNA levels and apoptosis in B-cell chronic lymphocytic leukemia (B-CLL): A quantitative analysis..
98:362A-362A.
2001
-
Dose dense, high intensity therapy for mantle cell lymphoma..
98:681A-682A.
2001
-
Durable engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen for adults..
98:185A-185A.
2001
-
Enrichment of donor erythroid cells after non-myeloablative bone marrow transplantation (BMT) for sickle cell anemia (SCA)..
98:490A-490A.
2001
-
Flow cytometric analysis in two large cohorts of patients with PNH..
98:221A-221A.
2001
-
Functional T cell immunity before myeloid engraftment by donor post-thymic T cells in pediatric unrelated cord blood transplant recipients..
98:379A-379A.
2001
-
High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc)..
98:395B-395B.
2001
-
Impaired anticoagulant response to thrombin improves after regression of atherosclerosis in monkeys..
98:257A-257A.
2001
-
Increased microvessel density in non-Hodgkin's lymphoma (NHL) is localized to the site of disease changes in accordance with disease response..
98:236B-236B.
2001
-
J82 cell inositol polyphosphatide signaling via factor Xa and factor VIIa: The possible role of protease-activated receptor 2 (PAR-2) activation..
98:53B-53B.
2001
-
Lack of standardization of methodology for enumeration of CD34 in banked umbilical cord blood..
98:333B-333B.
2001
-
Low dose, weekly, paclitaxel as salvage therapy for non-Hodgkins lymphoma (NHL)..
98:246B-246B.
2001
-
MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD..
98:200A-200A.
2001
-
Molecular evidence of engraftment in bone marrow after nonmyeloablative allogeneic stem cell transplant (NMASCT) is an unreliable indicator of residual/recurrent disease in the marrow..
98:185A-185A.
2001
-
Molecular interaction of the Fanconi Anemia (FA) and Ataxia Telangiectasia (AT) pathways..
98:782A-782A.
2001
-
Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population..
98:853A-853A.
2001
-
Non-myeloablative allogeneic transplantation using T depleted matched sibling peripheral blood stem cells..
98:420A-421A.
2001
-
Non-myeloablative transplantation using CAMPATH 1H for T depletion of mismatched, related donor peripheral blood stem cells..
98:669A-669A.
2001
-
PRA reduction after sublethal preconditioning and hematopoietic reconstitution with Campath-1-treated mobilized peripheral blood..
98:315B-315B.
2001
-
Phase I trial of prolonged infusion gemcitabine with fludarabine for relapsed/refractory acute leukemia..
98:220B-221B.
2001
-
Prolonged infusion gemcitabine in combination with CPT-11 for relapsed or refractory hematologic malignancies..
98:209B-209B.
2001
-
Radiolabeled anti-tenascin antibody for refractory non-Hodgkins lymphoma (NHL)..
98:247B-247B.
2001
-
Reconstitution of T cell and dendritic cell immunity 50 days post unrelated cord blood transplant predicts the incidence of opportunistic infections and acute GVHD in children..
98:204A-204A.
2001
-
Red cell signaling pathways cause increased sickle cell adhesion to non-activated endothelial cells..
98:484A-484A.
2001
-
Regulation of T and NK cell mediated cytotoxicity by the CD7 ligand, k12..
98:23A-23A.
2001
-
Sickle red cell B-CAM/LU mediates adhesion to multiple sites of laminin under different conditions..
98:484A-485A.
2001
-
The clinical course of PNH in the USA and in Japan..
98:220A-220A.
2001
-
Translocations of the MLL gene can be detected in an increased proportion of mononuclear cells collected after etoposide priming in patients subsequently developing secondary acute leukemia..
98:401A-402A.
2001
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT)..
98:687A-687A.
2001
-
Unique molecular characteristics of primitive human AML cells permit apoptosis to be specifically induced in leukemic but not normal stem cells..
98:93A-93A.
2001
-
alpha-adducin connects actin filament barbed ends to the platelet membrane skeleton..
98:787A-787A.
2001
-
Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia..
98:2917-2921.
2001
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA..
98:2442-2447.
2001
-
Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells..
98:2301-2307.
2001
-
Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey..
98:2345-2351.
2001
-
Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL..
98:2052-2058.
2001
-
Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome..
98:1321-1325.
2001
-
Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8..
98:1252-1254.
2001
-
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine..
98:548-553.
2001
-
Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: evidence for selective modulation of FGF-2-induced angiogenesis..
97:3450-3457.
2001
-
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)..
97:3574-3580.
2001
-
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis..
97:2998-3003.
2001
-
T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation..
97:2896-2899.
2001
-
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells..
97:2177-2179.
2001
-
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01..
97:1211-1218.
2001
-
Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation..
97:1289-1297.
2001
-
Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation..
97:880-885.
2001
-
Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders..
97:1138-1140.
2001
-
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency..
97:809-811.
2001
-
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial..
97:404-409.
2001
-
Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b..
97:376-382.
2001
-
Adoptive immunotherapy with allogeneic EBV CTL for organ transplant patients with ebv induced lymphoproliferative disease.
96.
2000
-
Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+ cell count in cord blood: The coblt experience.
96.
2000
-
Binding and activation of monocytes by pf4/heparin specific antibodies.
96.
2000
-
CD2-mediated IL-12-dependent signals render human γδ-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: Implications for the development of adoptive immunotherapy strategies.
96:3827-3837.
2000
-
Circulating pig-a mutant t lymphocytes in healthy adults and patients with bone marrow failure syndromes including pnh.
96.
2000
-
Combination treatment of bullous skin gvhd with ANTI-CD20 and ANTI-CD25 antibodies.
96.
2000
-
Cytokine regulation of inducffile nitric oxide synthase (nos2) and nos2 inhibitor-induced apoptosis and death in chronic lymphocytic leukemia cells.
96.
2000
-
Effect of age and replicative stress on hematopoietic stem cell telomere length.
96.
2000
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model demonstrates the requirement for human platelet factor 4 and platelet activation through fcyriia.
96.
2000
-
High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis fed.
96.
2000
-
Human erythrocyte and endothelial cells contain tbs ce transglutaminase that can regulates inflammation a nd platelet function by binding and releasing nitric oxde.
96.
2000
-
Hyperhomocysteenemia induces alterations in fffirinogen function and fibrin clot structure in a rabbit model.
96.
2000
-
In vivo behavior of factor ix and certain gla domain mutants evaluated in coagulation factor k-deficient mice.
96.
2000
-
Inhibition of tyrosine kinase activity by sugen 5416 inhibits fibrin dependent angiogenesis.
96.
2000
-
Interchangeabelity of cytokine receptor signals during terminal myeloid differentiation: erythropoietin receptor (epor) signals support granulocytic differentiation and induction of myeloid gene expression.
96.
2000
-
Nitric oxide asa nonprotein regulator of hematopoietic cell proliferation and differentiation-relationship to malarial anemia.
96.
2000
-
Notch1 perturbation of lymphoid b and myeloid development is associated with upregulation of hes1/ hes5 and secreted factors.
96.
2000
-
Novel nuclear target for thrombin: activation of the Elk1 transcription factor leads to chemokine gene expression..
96:3696-3706.
2000
-
Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank.
96.
2000
-
Phase i trial of continuously infused gemcitabine with cpt-11 for refractory hematologic malignancies.
96.
2000
-
Preliminary characterization of the surface staining of placental derived adherent cells: a potential new source of stroma for umbilical cord blood (ucb) expansion.
96.
2000
-
Quantitative modelling to predict candidates for outpatient blood and/or marrow transplantation (BMT).
96.
2000
-
Relationship between transferrin saturation and iron stores in U.S. African-american and caucasian populations.
96.
2000
-
Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo.
96.
2000
-
Unrelated umbilical cord blood transplant for osteopetrosis.
96.
2000
-
Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+cell count in cord blood: The COBLT experience..
96:302B-302B.
2000
-
Banked umbilical cord blood is an excellent source of donor hematopoietic stem cells for infants with malignant and non-malignant conditions lacking a related donor..
96:587A-+.
2000
-
Binding and activation of monocytes by PF4/heparin specific antibodies..
96:269A-269A.
2000
-
Characterization of HLA polymorphism in an ethnically diverse cord blood bank..
96:301B-301B.
2000
-
Chimerism mediated immunotherapy using Campath T cell depleted peripheral blood progenitor cells (PBPC) with nonablative therapy provides reliable, durable allogeneic engraftment..
96:521A-521A.
2000
-
Cytokine regulation of inducible nitric oxide synthase (NOS2) and NOS2 inhibitor-induced apoptosis and death in chronic lymphocytic leukemia cells..
96:159A-159A.
2000
-
Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) after high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected stem cell transplantation (SCT) for severe autoimmune diseases..
96:406A-406A.
2000
-
Expression of tumor suppressor genes IRF-1 and DAP-kinase in primitive AML cells..
96:696A-696A.
2000
-
Hematopoietic engraftment and survival after unrelated donor umbilical cord blood (UCB) transplantation in adult recipients..
96:587A-+.
2000
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model demonstrates the requirement for human platelet factor 4 and platelet activation through Fc gamma RIIA..
96:221A-221A.
2000
-
High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis (FEL)..
96:362B-362B.
2000
-
High-dose immunosuppressive therapy (HDIT) and autologous stem cell transplant for severe systemic sclerosis (SSc)..
96:844A-844A.
2000
-
Human erythrocyte and endothelial cells contain tissue transglutaminase that can regulates inflammation and platelet function by binding and releasing nitric oxide..
96:38A-38A.
2000
-
In vivo behavior of factor IX and certain GLA domain mutants evaluated in coagulation factor M-deficient mice..
96:35A-35A.
2000
-
Induction of apoptosis in primitive human AML cells using the proteasome inhibitor MG-132 and/or sodium salicylate..
96:80A-80A.
2000
-
Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis..
96:57B-57B.
2000
-
Inverse relationship of plasma prostaglandin-E-2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria..
96:31B-31B.
2000
-
Limitations of using CD23 expression by flow cytometry to differentiate mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma..
96:330A-330A.
2000
-
Low incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorders (EBV-PTLD) in 263 unrelated donor umbilical cord blood transplant recipients..
96:206A-206A.
2000
-
Nitric oxide as a nonprotein regulator of hematopoietic cell proliferation and differentiation-relationship to malarial anemia..
96:14B-14B.
2000
-
Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank..
96:206A-206A.
2000
-
Overexpression of anti-apoptosis genes in association with resistance to apoptosis observed in bone marrow failure syndromes..
96:526A-526A.
2000
-
Oxygen-dependent export of nitric oxide from red blood cells..
96:596A-+.
2000
-
Pediatric ALK-positive lymphomas coexpress c-Myc..
96:128A-128A.
2000
-
Phase I trial of continuously infused gemcitabine with CPT-11 for refractory hematologic malignancies..
96:216B-216B.
2000
-
Phase I trial of continuously infused gemcitabine with mitoxantrone for high risk or relapsed acute leukemia..
96:326A-326A.
2000
-
Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia..
96:385A-385A.
2000
-
Predictive value of day+50 immune reconstitution on the incidence of opportunistic infections and acute GVHD following unrelated cord blood transplants in children..
96:789A-789A.
2000
-
Preliminary characterization of the surface staining of placental derived adherent cells: A potential new source of stroma for umbilical cord blood (UCB) expansion..
96:150B-150B.
2000
-
Relationship between transferrin saturation and iron stores in US African-American and Caucasian populations..
96:226A-226A.
2000
-
Serum alpha-2 macroglobulin (alpha 2M) determines NAT binding capacity in patients with peripheral vascular disease (PVD)..
96:273A-273A.
2000
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT)..
96:842A-843A.
2000
-
Umbilical cord blood graft engineering using bone marrow stroma to enhance hematopoietic stem and progenitor cell content..
96:774A-774A.
2000
-
Unrelated umbilical cord blood transplant for osteopetrosis..
96:207A-207A.
2000
-
Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture..
96:754A-754A.
2000
-
A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment..
96:3499-3504.
2000
-
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer..
96:3001-3007.
2000
-
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells..
96:2828-2833.
2000
-
Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S..
96:2358-2363.
2000
-
Signaling via LAT (linker for T-cell activation) and Syk/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation..
96:2181-2190.
2000
-
A topological study of the human gamma-glutamyl carboxylase..
96:973-978.
2000
-
Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases..
95:2913-2921.
2000
-
Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506..
95:2733-2741.
2000
-
X-linked genetic factors regulate hematopoietic stem-cell kinetics in females..
95:2449-2451.
2000
-
Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report.
95:1918-1924.
2000
-
Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease..
95:1918-1924.
2000
-
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies..
95:1533-1540.
2000
-
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality..
95:1743-1751.
2000
-
PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice..
95:705-710.
2000
-
Addition of stem cells from allogeneic donors accelerates engraftment and immune reconstitution after stem cell transplantation.
96:171a.
2000
-
Inverse relationship of plasma prostaglandin-E2
and blood mononuclear cell cyclooxygenase-2 with disease severity in children with plasmodium falciparum malaria.
96:31b.
2000
-
Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model.
96:309b.
2000
-
Prevalence of hepatitis c in adults with sickle cell disease.
96:15b.
2000
-
Sustained expression of human factor VIII in mice using a parvovirus- based vector.
95:1594-1599.
2000
-
The molecular defect in hypotransferrinemic mice.
96:1113-1118.
2000
-
Normal neutrophil function in cathepsin G-deficient mice..
94:4282-4293.
1999
-
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha..
94:4233-4246.
1999
-
A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies..
94:629A-629A.
1999
-
Absolute lymphoid and myeloid dendritic cell counts in umbilical cord blood grafts and in recipients of unrelated umbilical cord blood transplants..
94:326B-326B.
1999
-
Acute lymphoblastic leukemia in infancy: Improved outcome with unrelated placental cord blood (PCB) transplants..
94:712A-712A.
1999
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expaned cells, a phase I trial using the replicell system..
94:571A-571A.
1999
-
Cell cycle analyses and apoptosis in primitive leukemic and normal cells..
94:687A-687A.
1999
-
Characterization of a monoclonal antibody to PF4/heparin (KKO) with functional and serologic properties of hit antibodies..
94:21A-21A.
1999
-
Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation for mucopolysaccharidosis type 6: Report of 3 cases..
94:334A-335A.
1999
-
Evaluation of thalidomide for the treatment of chronic graft-versus-host disease in "high risk" patients..
94:158A-158A.
1999
-
Human platelet adducin: A regulated actin filament barbed end-capping protein..
94:216A-216A.
1999
-
Inducible nitric oxide synthase (NOS2) inhibitors induce high level CLL cell apoptosis and death..
94:703A-703A.
1999
-
Laminin binding and B-CAM/LU expression by high and low density reticulocytes vs mature red cells in sickle cell disease..
94:675A-675A.
1999
-
Manipulation of CD22 signal transduction for the treatment of lymphoma..
94:93A-93A.
1999
-
Markers of angiogenesis, factor VIII and tenascin, correlate with disease activity in patients with Non-Hodgkin's Lymphoma..
94:253B-253B.
1999
-
Stable mixed chimerism after bone marrow transplantation (BMT) for Sickle Cell Disease (SCD)..
94:645A-645A.
1999
-
Stroma from adult bone marrow increases the productivity of ex vivo cord blood expansion cultures..
94:164B-164B.
1999
-
The effect of cytokine combinations on the clinical scale ex-vivo expansion of umbilical cord blood..
94:573A-573A.
1999
-
The interleukin-3 receptor alpha chain is highly expressed on primitive acute myelogenous leukemia cells..
94:67A-67A.
1999
-
Transplantation of a patient with congenital neutropenia and invasive fungal disease with unrelated umbilical cord blood using paternal G-CSF mobilized, irradiated granulocyte support..
94:368B-369B.
1999
-
Unrelated umbilical cord blood transplants in adult patients (pts) with hematologic malignancies or genetic disorders..
94:570A-570A.
1999
-
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study..
94:2208-2216.
1999
-
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group..
94:1550-1554.
1999
-
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group..
94:1550-1554.
1999
-
CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade..
94:1382-1392.
1999
-
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone..
94:340-347.
1999
-
Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes..
94:793-802.
1999
-
Cirrhosis of the liver in long-term marrow transplant survivors..
93:3259-3266.
1999
-
Rapid telomere shortening in children..
93:2824-2830.
1999
-
Optimal proliferation of a hematopoietic progenitor cell line requires either costimulation with stem cell factor or increase of receptor expression that can be replaced by overexpression of Bcl-2..
93:2569-2577.
1999
-
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and Filgrastim in high-risk breast cancer patients.
93:2491-2501.
1999
-
Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions.
93:467-480.
1999
-
DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1..
93:399-409.
1999
-
The C282Y mutation causing hereditary hemochromatosis does not produce a null allele.
94:9-11.
1999
-
Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1..
92:4677-4690.
1998
-
A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells..
92:646A-646A.
1998
-
Busulfan and melphalan as preparative therapy for BMT in childhood leukemias..
92:128A-128A.
1998
-
Detection of inducible nitric oxide synthase (NOS2) mRNA, antigen and enzyme activity in leukemia cells from patients with CLL..
92:431A-431A.
1998
-
Enhanced fludarabine cytotoxicity in B-CLL lymphocytes by combination with nitric oxide donors or doxorubicin..
92:596A-596A.
1998
-
Long term disease free survival for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high dose therapy with hematopoietic support..
92:323A-323A.
1998
-
Mechanisms of resistance to apoptosis in granulocytes of patients with paroxysmal nocturnal hemoglobinuria..
92:6B-7B.
1998
-
Nitric oxide modulates extracellular matrix stabilization by inhibiting endothelial cell transglutaminase activity..
92:77B-77B.
1998
-
Prognostic factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high dose therapy with hematopoietic support..
92:462A-463A.
1998
-
Transient engraftment of maternal T-cells in recipients of unrelated cord blood transplants..
92:652A-653A.
1998
-
Transplantation of related, haplo-identical umbilical cord blood in pediatric patients with genetic hematological diseases..
92:358B-358B.
1998
-
Unrelated cord blood transplantation for correction of genetic diseases..
92:291A-291A.
1998
-
Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia..
92:3250-3259.
1998
-
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow..
92:3780-3792.
1998
-
Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML).
92:2600-2602.
1998
-
Role of JAK3 in CD40-mediated signaling..
92:2435-2440.
1998
-
The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria..
92:2541-2550.
1998
-
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111..
92:1556-1564.
1998
-
Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia..
92:1455-1456.
1998
-
The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells..
92:1219-1224.
1998
-
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase..
92:394-401.
1998
-
Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny..
92:83-92.
1998
-
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations..
91:4188-4196.
1998
-
Long-term outcome after marrow transplantation for severe aplastic anemia..
91:3637-3645.
1998
-
Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors..
91:3182-3192.
1998
-
Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group..
91:2601-2608.
1998
-
Distribution of transferrin saturations in the African-American population..
91:2175-2179.
1998
-
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
92:3804-3816.
1998
-
Gamma-globin gene promoter elements required for interaction with globin enhancers..
91:309-318.
1998
-
Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children.
91:2601-2608.
1998
-
Iron is hot: An update on the pathophysiology of hemochromatosis.
92:1845-1851.
1998
-
The G185R mutation disrupts function of the iron transporter Nramp2.
92:2157-2163.
1998
-
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease..
90:4705-4709.
1997
-
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy..
90:4313-4320.
1997
-
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study..
90:4532-4538.
1997
-
Acquired DNA mutations in adults with myeloproliferative disorders receiving hydroxyurea therapy..
90:1542-1542.
1997
-
B-CAM/LU protein: A single IgSF domain and copy number but not the cytoplasmic region are critical for laminin binding..
90:2685-2685.
1997
-
Clinical-scale expansion of human umbilical cord blood cells in an automated perfused culture system..
90:4283-4283.
1997
-
Correction of beta thalassemia major with umbilical cord blood transplantation from a related haploidentical donor..
90:4536-4536.
1997
-
Ex vivo expansion and retroviral vector transduction of umbilical cord food (UCB) platelet progenitors..
90:2392-2392.
1997
-
Extrathymic stem cells develop into dendritic cells in human thymic microenvironments in vitro..
90:3382-3382.
1997
-
Hematopoietic recovery in adult recipients following unrelated umbilical cord blood (UCB) transplantation..
90:480-480.
1997
-
Immune recovery post unrelated allogeneic umbilical cord blood (UCB) transplantation in adult recipients..
90:1868-1868.
1997
-
Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes..
90:2083-2083.
1997
-
Marked of cytotoxicity of SN-38 and novel camptothecin derivatives to chronic B-cell lymphocytic leukemia lymphocytes in vitro..
90:2371-2371.
1997
-
Marked radiographic improvement in infantile hypophosphatasia with T-depleted bone marrow transplantation from a related haploidentical donor..
90:4537-4537.
1997
-
The transglutaminase enzyme derived from vascular cells contributes to the proangiogenic properties of fibrin..
90:3043-3043.
1997
-
Transplantation of unrelated donor umbilical cord blood (UCB): Outcomes and analysis of risk factors..
90:1767-1767.
1997
-
Unrelated donor stem cell transplant for Fanconi anemia: Multicenter report of forty-nine cases.
90:474-474.
1997
-
Unrelated placental cord blood transplantation in a patient with sickle cell disease and acute non-lymphocytic leukemia..
90:4542-4542.
1997
-
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients..
90:2939-2951.
1997
-
Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-1 on leukocytes..
90:2381-2389.
1997
-
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy..
90:2406-2416.
1997
-
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia..
90:1410-1414.
1997
-
T helper 2-dominant antilymphoma immune response is associated with fatal outcome..
90:1611-1617.
1997
-
Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene..
89:4628-4635.
1997
-
Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression..
89:3925-3935.
1997
-
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose..
89:4226-4235.
1997
-
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial..
89:3880-3887.
1997
-
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin..
89:3890-3891.
1997
-
Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding..
89:3175-3185.
1997
-
Adenosine deaminase deficiency in adults..
89:2849-2855.
1997
-
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation..
89:3055-3060.
1997
-
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency..
89:1968-1977.
1997
-
Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease..
89:1452-1459.
1997
-
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022..
89:780-788.
1997
-
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices..
89:801-813.
1997
-
Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis..
89:370-375.
1997
-
FcγRIIA H/R131
polymorphism, subclass-specific IgG anti- heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
89:370-375.
1997
-
Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients.
90:2196-2206.
1997
-
2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies..
88:2666-2666.
1996
-
A conserved element in the human CD7 promoter binds dbpA and a novel zinc finger protein..
88:770-770.
1996
-
AXL receptor tyrosine kinase mediates ligand dependent cell adhesion and is expressed in mature bone marrow monocytes..
88:2130-2130.
1996
-
Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy..
88:2055-2055.
1996
-
BCAM/LU protein: A novel laminin receptor overexpressed by sickle erythrocytes.
88:13-13.
1996
-
Characterization of K12, a novel molecule with potential growth promoting activity produced by granulocytes.
88:65-65.
1996
-
Gamma globin promoter elements required for interaction with globin enhancers..
88:595-595.
1996
-
Growth factor modulation of p21(WAF1/CIP1) in primary acute myeloid leukemias..
88:331-331.
1996
-
Hematopoietic engraftment using placental cord blood (PCB) unrelated donor transplantation in recipients >40 kg weight..
88:1051-1051.
1996
-
Increased prevalence of Kaposi's sarcoma-associated herpesvirus in peripheral blood mononuclear cells of HIV-infected homosexuals..
88:1992-1992.
1996
-
Multiparameter fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells..
88:1727-1727.
1996
-
New York blood center's program for unrelated placental umbilical cord blood (PCB) transplantation: 243 transplants in the first 3 years..
88:557-557.
1996
-
PE-2 (ERF), a novel ETS factor, is hypophosphorylated in c-kit(+) K562 cells..
88:3183-3183.
1996
-
Pharmacokinetics of arabinosylguanine (ara-G) and its triphosphate (ara-GTP) during a phase I trial of compound GW506U in refractory hematologic malignancies: Correlation with response..
88:2667-2667.
1996
-
Report on patients with glycogen storage disease 1b with severe chronic neutropenia (SCN) treated with filgrastim..
88:1383-1383.
1996
-
Schedule dependent growth inhibition and induction of apoptosis by nitric oxide in leukemia cells..
88:269-269.
1996
-
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors..
88:3634-3641.
1996
-
P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells..
88:3010-3021.
1996
-
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia..
88:2473-2479.
1996
-
Nitric oxide interactions with cobalamins: biochemical and functional consequences..
88:1857-1864.
1996
-
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells..
88:1551-1560.
1996
-
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation..
88:824-830.
1996
-
Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation..
87:4723-4730.
1996
-
Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice..
87:4325-4332.
1996
-
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation..
87:3045-3052.
1996
-
Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets..
87:2322-2328.
1996
-
Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells..
87:977-982.
1996
-
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
87:3607-3614.
1996
-
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors..
87:51-58.
1996
-
Human CD34+
hematopoietic progenitors have low, cytokine-unresponsive O6
-alkylguanine-DNA alkyltransferase and are sensitive to O6
-benzylguanine plus BCNU.
88:1649-1655.
1996
-
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients..
87:386-392.
1996
-
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine [1].
88:2354-2355.
1996
-
A novel insert at the 5' end of the human inducible nitric oxide synthase gene..
86:115-115.
1995
-
Compound 506 (2-amino-6-methoxypurine arabinoside) is active against resistant T-cell malignancies: Preliminary results of a Phase I trial prior to definition of a MTD..
86:2034-2034.
1995
-
DNA damage induced apoptosis by p53-mediated activation of p34(cdc2) kinase..
86:1714-1714.
1995
-
Ectopic and elevated expression of a novel receptor tyrosine kinase C-MER, may distinguish a subset of childhood T cell acute lymphatic leukemias..
86:3029-3029.
1995
-
Erythroid progenitors express a CD44 variant with reduced hyaluronic acid binding ability and reduced expression of the epitope associated with Hemophilus influenzae hemagglutination.
86:1876-1876.
1995
-
Flow cytometric detection of gene transfer into progenitor cells from cryopreserved umbilical cord blood (UCB)..
86:937-937.
1995
-
Inhibition of HIV-1 integrase by hydroxocobalamin.
86:2231-2231.
1995
-
Isolation and characterization of a novel ETS factor, PE-2..
86:2632-2632.
1995
-
Modulation of hyaluronan binding to CD44H..
86:1877-1877.
1995
-
Nitric oxide and cobalamins: NO-Cb1 interactions with light, oxygen, hemoglobin, and glutathione..
86:494-494.
1995
-
Structure of the mouse CD83 gene.
86:1280-1280.
1995
-
T cell lymphoblastic leukemia with mediastinal mass and c-kit expression..
86:3095-3095.
1995
-
The hematopoietic defect in paroxysmal nocturnal hemoglobinuria assessed by long-term bone marrow culture..
86:511-511.
1995
-
The oncogenic E2A-HLF fusion protein protects leukemic B-precursor cells from apoptosis..
86:1297-1297.
1995
-
Umbilical cord blood: An alternative source of hemopoietic stem cells for bone marrow reconstitution in unrelated donor transplantation..
86:1147-1147.
1995
-
Vascular localization of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor..
86:1493-1493.
1995
-
A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells..
86:3295-3301.
1995
-
Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma..
86:2900-2905.
1995
-
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia..
86:2028-2032.
1995
-
Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation..
86:1794-1801.
1995
-
Prevalence of heterozygotes for hemochromatosis in the white population of the United States..
86:2021-2027.
1995
-
Inhibition of productive human immunodeficiency virus-1 infection by cobalamins..
86:1281-1287.
1995
-
Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages..
86:1184-1195.
1995
-
Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia..
85:3353-3354.
1995
-
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma..
85:3334-3341.
1995
-
Telomerase activity in normal leukocytes and in hematologic malignancies..
85:2315-2320.
1995
-
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811.
85:2025-2037.
1995
-
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811..
85:2025-2037.
1995
-
Neurologic complications after allogeneic marrow transplantation for sickle cell anemia..
85:879-884.
1995
-
Erythrocyte blood group antigens: not so simple after all..
85:299-306.
1995
-
Lectin and epidermal growth factor domains of P-selectin at physiologic density are the recognition unit for leukocyte binding..
85:151-158.
1995
-
CHARACTERIZATION OF A NOVEL ECTO-ADP-RIBOSYL-TRANSFERASE IN T-LYMPHOCYTES BY THE B-SUBUNIT OF PERTUSSIS TOXIN.
84:A432-A432.
1994
-
COBALAMINS AND AIDS - POTENT INHIBITION OF HIV-1 INFECTION OF HUMAN MONOCYTES, PERITONEAL-MACROPHAGES, AND BLOOD MONONUCLEAR-CELLS IN-VITRO BY HYDROXOCOBALAMIN, METHYLCOBALAMIN, OR ADENOSYLCOBALAMIN.
84:A480-A480.
1994
-
DEOXYCOFORMYCIN IS ACTIVE AGAINST LANGERHANS CELL HISTIOCYTOSIS.
84:A596-A596.
1994
-
EVIDENCE THAT CDW108 MEMBRANE-PROTEIN BEARS THE JMH BLOOD-GROUP ANTIGEN.
84:A237-A237.
1994
-
G-CSF-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) COLLECTED IN THE STEADY-STATE ARE SUPERIOR TO G-CSF-PRIMED PBPCS COLLECTED ON THE REBOUND FROM CHEMOTHERAPY.
84:A107-A107.
1994
-
NITRIC-OXIDE COBALAMIN INTERACTIONS - IMPLICATIONS REGARDING VITAMIN-B12 DEFICIENCY STATES.
84:A118-A118.
1994
-
NITRIC-OXIDE INHIBITS THE GROWTH OF HUMAN BONE-MARROW COLONIES BY A DIRECT EFFECT ON CD34+ CELLS.
84:A268-A268.
1994
-
PHASE-I CONCENTRATION-CONTROLLED, ESCALATION TRIAL OF LISOFYLLINE (LSF) IN PATIENTS (PTS) UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT).
84:A89-A89.
1994
-
SECONDARY T-CELL DEPLETED (TCD) MARROW BOOST FOR DELAYED IMMUNE RECOVERY FOLLOWING T-DEPLETED BONE-MARROW TRANSPLANTATION (BMT).
84:A491-A491.
1994
-
SUCCESSFUL TREATMENT (RX) OF PATIENTS (PTS) WITH REFRACTORY SEVERE APLASTIC-ANEMIA (SAA) WITH CONCOMITANT CYCLOSPORINE (CSA) AND COLONY-STIMULATING FACTORS (CSF).
84:A10-A10.
1994
-
THE CD45 TYROSINE PROTEIN-KINASE IS NOT REQUIRED FOR SIGNALING AND ACTIVATION OF HUMAN T-LYMPHOCYTES BY THE PERTUSSIS TOXIN RECEPTOR.
84:A285-A285.
1994
-
THE PATHOGENESIS OF INTERLEUKIN-2 CYTOTOXICITY TO HUMAN STEM-CELL LEUKEMIA IN SCID MICE.
84:A47-A47.
1994
-
Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology..
84:3205-3211.
1994
-
Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules..
84:2802-2810.
1994
-
Inhibition of leukocyte L-selectin function with a monoclonal antibody attenuates reperfusion injury to the rabbit ear..
84:2322-2328.
1994
-
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
84:1672-1679.
1994
-
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase..
84:1672-1679.
1994
-
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation..
84:1680-1684.
1994
-
The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen..
84:1402-1407.
1994
-
Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes..
84:1276-1282.
1994
-
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
84:941-949.
1994
-
Inter-VH-gene-family shared idiotype on acquired immunodeficiency syndrome-associated lymphomas..
84:986-987.
1994
-
ACTIVATION OF FACTOR-X BY FACTOR VIIA ON MONOCYTE CELL-SURFACES.
83:3828-3828.
1994
-
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support..
83:3132-3137.
1994
-
Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors..
83:3417-3418.
1994
-
von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene..
83:3225-3231.
1994
-
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation..
83:2823-2828.
1994
-
Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting..
83:2851-2859.
1994
-
High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma..
83:1903-1908.
1994
-
The cell and molecular basis of leukocyte common antigen (CD45)-triggered, lymphocyte function-associated antigen-1-/intercellular adhesion molecule-1-dependent, leukocyte adhesion..
83:1862-1870.
1994
-
Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity..
83:1595-1602.
1994
-
Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations..
83:1551-1557.
1994
-
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia..
83:1603-1611.
1994
-
A novel beta-globin mutation, beta Durham-NC [beta 114 Leu-->Pro], produces a dominant thalassemia-like phenotype..
83:1109-1116.
1994
-
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step..
83:816-821.
1994
-
Release of tumor cells from bone marrow..
83:623-625.
1994
-
Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia..
83:38-42.
1994
-
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [1].
83:2749-2750.
1994
-
Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
84:2036-2043.
1994
-
A SINGLE 6-HOUR (HR) STEADY-STATE LEUKAPHERESIS IS SUFFICIENT FOR COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AFTER G-CSF.
82:A349-A349.
1993
-
COMPUTER IMAGING OF BETA-DURHAM-NC [BETA(114) LEU-]PRO], A THALASSEMIC HEMOGLOBINOPATHY.
82:A358-A358.
1993
-
EFFECT OF NITRIC-OXIDE (NO) ON THE GROWTH AND DIFFERENTIATION OF FRESHLY ISOLATED ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) CELLS.
82:A491-A491.
1993
-
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY.
82:A293-A293.
1993
-
EXPRESSION OF C-KIT RECEPTORS AND KIT-LIGAND IN HUMAN THYMOCYTES AND THYMUS TISSUE.
82:A244-A244.
1993
-
HAPLOIDENTICAL TRANSPLANTATION OF UMBILICAL-CORD BLOOD MONONUCLEAR-CELLS IN A PEDIATRIC-PATIENT WITH AML.
82:A634-A634.
1993
-
HUMAN MONONUCLEAR PHAGOCYTE NITRIC-OXIDE SYNTHASE (NOS) - EVIDENCE FOR INDUCTION OF NOS MESSENGER-RNA AND PROTEIN WITHOUT DETECTABLE CAPACITY FOR NITRIC-OXIDE PRODUCTION.
82:A186-A186.
1993
-
INVESTIGATION OF THE HOLLEY GREGORY DOMBROCK BLOOD-GROUP ANTIGEN PROTEIN USING A NOVEL MONOCLONAL-ANTIBODY.
82:A267-A267.
1993
-
LOCALIZATION OF THE GENE FOR INDUCIBLE NITRIC-OXIDE SYNTHASE TO DISTAL MOUSE CHROMOSOME-11 - RELEVANCE TO INFLAMMATION, ARTHRITIS, DIABETES-MELLITUS, AND AUTOIMMUNITY.
82:A29-A29.
1993
-
MONOCYTE CHEMOATTRACTANT ACTIVITY OF ACTIVE-SITE MUTANT RECOMBINANT THROMBIN AND THROMBIN RECEPTOR PEPTIDE SFLLRN.
82:A26-A26.
1993
-
REGULATION OF ALTERNATIVELY SPLICED CD45 MESSENGER-RNA TRANSCRIPTS DURING T-CELL MATURATION.
82:A244-A244.
1993
-
SYNOVIAL LINING MACROPHAGES IN RHEUMATOID-ARTHRITIS PREFERENTIALLY EXPRESS SPECIFIC CD44-VARIANT ISOFORMS COMPARED TO OTHER TISSUE MACROPHAGES.
82:A32-A32.
1993
-
THE CD3-T CELL ANTIGEN RECEPTOR COMPLEX REGULATES PERTUSSIS TOXIN RECEPTOR-STIMULATED TYROSINE PROTEIN-PHOSPHORYLATION.
82:A246-A246.
1993
-
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission..
82:2920-2928.
1993
-
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583..
82:2975-2984.
1993
-
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma..
82:2568-2576.
1993
-
L-selectin can mediate leukocyte rolling in untreated mesenteric venules in vivo independent of E- or P-selectin..
82:1632-1638.
1993
-
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria..
82:1192-1196.
1993
-
Characterization of the DNase I hypersensitive site 3' of the human beta globin gene domain..
81:2781-2790.
1993
-
Volume and osmotic properties of human neutrophils..
81:2774-2780.
1993
-
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia..
81:2496-2502.
1993
-
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy..
81:2031-2035.
1993
-
Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy..
81:1709-1719.
1993
-
Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor..
81:1787-1791.
1993
-
Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus..
81:1290-1299.
1993
-
Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein..
81:928-934.
1993
-
Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis..
81:720-725.
1993
-
Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype..
81:815-819.
1993
-
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia..
81:319-323.
1993
-
Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma..
81:166-176.
1993
-
Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients..
80:2128-2135.
1992
-
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate..
80:1838-1845.
1992
-
Nitric oxide modulation of human leukemia cell differentiation and gene expression..
80:1880-1884.
1992
-
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency..
80:1163-1171.
1992
-
Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factors..
80:1183-1189.
1992
-
Dynamic assessment of quality of life after autologous bone marrow transplantation..
80:825-830.
1992
-
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation..
79:3337-3343.
1992
-
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia..
79:3091-3092.
1992
-
HYDROXYUREA - SPECIFIC THERAPY FOR SICKLE-CELL-ANEMIA.
79:2503-2506.
1992
-
Cardiopulmonary bypass induces leukocyte-platelet adhesion..
79:1201-1205.
1992
-
Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein..
79:1574-1581.
1992
-
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion..
79:576-585.
1992
-
Spontaneous delta- to beta-globin switching in K562 human leukemia cells..
79:820-825.
1992
-
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation..
79:517-526.
1992
-
Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone..
79:289-291.
1992
-
Immunosuppressive therapy of aplastic anemia: Results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
79:2566-2571.
1992
-
Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.
79:2572-2577.
1992
-
Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction..
79:38-44.
1992
-
Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages..
78:3128-3132.
1991
-
A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group..
78:3133-3141.
1991
-
The promoter of human T-cell leukemia virus type-I is repressed by the immediate-early gene region of human cytomegalovirus in primary blood lymphocytes..
78:2956-2961.
1991
-
Relationship of clinical severity to packed cell rheology in sickle cell anemia..
78:2735-2739.
1991
-
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update)..
78:2514-2519.
1991
-
Adducin in erythrocyte precursor cells of rats and humans: expression and compartmentalization..
78:1692-1696.
1991
-
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission..
78:1923-1927.
1991
-
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer..
78:1420-1427.
1991
-
Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype..
78:1603-1606.
1991
-
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts..
78:1144-1145.
1991
-
High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway..
78:700-702.
1991
-
Hepatitis C infection in children with hemophilia A and B..
78:285-289.
1991
-
Peritoneal fluid and plasma levels of human macrophage colony-stimulating factor in relation to peritoneal fluid macrophage content..
78:513-516.
1991
-
A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy..
77:2079-2084.
1991
-
Purification and partial characterization of a human hematopoietic precursor population..
77:2122-2128.
1991
-
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination..
77:1829-1836.
1991
-
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens..
77:1660-1665.
1991
-
Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells..
77:1681-1690.
1991
-
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors..
77:1111-1117.
1991
-
High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes..
77:376-380.
1991
-
Isolation and characterization of an acquired antithrombin antibody..
76:2249-2257.
1990
-
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens..
76:1867-1871.
1990
-
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment..
76:1464-1472.
1990
-
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma..
76:1293-1298.
1990
-
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease..
76:1431-1437.
1990
-
The influence of oxygen tension, temperature, and hemoglobin concentration on the rheologic properties of sickle erythrocytes..
76:1256-1261.
1990
-
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?.
76:1037-1045.
1990
-
Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3..
76:842-848.
1990
-
Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse..
76:73-79.
1990
-
Long- and short-lived murine hematopoietic stem cell clones individually identified with retroviral integration markers..
75:2267-2270.
1990
-
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells..
75:1947-1950.
1990
-
Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders..
75:1699-1704.
1990
-
Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins..
75:1404-1407.
1990
-
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study..
75:166-173.
1990
-
Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
76:228-234.
1990
-
Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNAs are produced by a small fraction of blood mononuclear cells..
74:1525-1530.
1989
-
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin..
74:1728-1737.
1989
-
Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells..
74:1517-1524.
1989
-
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model..
74:547-550.
1989
-
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance..
74:326-333.
1989
-
The Inab phenotype: characterization of the membrane protein and complement regulatory defect..
74:437-441.
1989
-
Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes..
73:2128-2132.
1989
-
Expression of protooncogene c-myb in normal human hematopoietic cells..
73:1444-1451.
1989
-
Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity..
73:1682-1685.
1989
-
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia..
73:1720-1728.
1989
-
Essential amino acid deprivation induces monocytic differentiation of the human HL-60 myeloid leukemia cell line..
73:1298-1306.
1989
-
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines..
73:945-951.
1989
-
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells..
73:381-390.
1989
-
Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p80..
73:596-600.
1989
-
Age as a prognostic factor in multiple myeloma..
73:353.
1989
-
Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma..
73:318-323.
1989
-
A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases..
72:1861-1869.
1988
-
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration..
72:1978-1984.
1988
-
Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage..
72:1790-1796.
1988
-
Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans..
72:1310-1315.
1988
-
Donor buffy coat cell infusion after marrow transplantation for aplastic anemia..
72:1099-1100.
1988
-
Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease..
72:721-727.
1988
-
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation..
72:546-554.
1988
-
Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes..
72:128-133.
1988
-
Decline in rates of clearance of IgG-sensitized erythrocytes with increasing age..
71:1726-1730.
1988
-
Preparation of polyethylene glycol-tissue plasminogen activator adducts that retain functional activity: characteristics and behavior in three animal species..
71:1641-1647.
1988
-
The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin..
71:1321-1328.
1988
-
Cooperative effect of tumor necrosis factor and gamma-interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cells..
71:1062-1067.
1988
-
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials..
71:293-298.
1988
-
Further characterization of erythrocyte p80 and the membrane protein defect of In(Lu) Lu(a-b-) erythrocytes..
70:1475-1481.
1987
-
Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumor necrosis factor: synergistic actions with interferon-gamma and 1,25-dihydroxyvitamin D3..
70:994-1002.
1987
-
Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors..
70:814-821.
1987
-
Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia..
70:247-253.
1987
-
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals..
70:173-176.
1987
-
Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin..
70:116-121.
1987
-
Activation of neutrophil superoxide production by concanavalin A can occur at low levels of intracellular ionized calcium..
69:762-768.
1987
-
Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets..
69:529-536.
1987
-
The role of glutathione reductase in maintaining human granulocyte function and sensitivity to exogenous H2O2..
69:493-500.
1987
-
Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors..
68:1363-1368.
1986
-
Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome..
68:1213-1217.
1986
-
Selenium-dependent glutathione peroxidase protein and activity: immunological investigations on cellular and plasma enzymes..
68:640-645.
1986
-
Dibutyryl cyclic adenosine monophosphate reduces expression of c-myc during HL-60 differentiation..
68:412-416.
1986
-
Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens..
68:417-425.
1986
-
Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease..
68:317-319.
1986
-
Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products..
67:1224-1228.
1986
-
Activation of human granulocytes by arachidonic acid: its use and limitations for investigating granulocyte functions..
67:1103-1109.
1986
-
Chemoattractant-mediated stimulation of the respiratory burst in human polymorphonuclear leukocytes may require appearance of protein kinase activity in the cells' particulate fraction..
67:909-913.
1986
-
Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria..
67:893-897.
1986
-
Bone marrow transplantation in patients aged 45 years and older.
67:770-776.
1986
-
Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study..
67:135-140.
1986
-
Growth and development following marrow transplantation for leukemia.
68:1129-1135.
1986
-
Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration..
67:203-206.
1986
-
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.
67:1172-1175.
1986
-
Phenotypic characterization of gamma interferon-induced human monocyte polykaryons..
66:1241-1246.
1985
-
Graded responses of human neutrophils induced by serum-treated zymosan..
66:1182-1188.
1985
-
The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane..
66:940-945.
1985
-
Antibody against T lymphoblastic leukemia-associated antigen (3-40) identifies vimentin and keratin intermediate filaments in normal cells..
66:642-648.
1985
-
Monoclonal antibody definition of T cell acute leukemia: a Pediatric Oncology Group study..
65:785-788.
1985
-
Catabolism of human tissue plasminogen activator in mice..
65:539-544.
1985
-
Human erythrocyte antigens: II. The In(Lu) gene regulates expression of an antigen on an 80-kilodalton protein of human erythrocytes..
64:599-606.
1984
-
Light scattering by polymorphonuclear leukocytes stimulated to aggregate under various pharmacologic conditions..
64:649-655.
1984
-
Characterization of an oligopeptide chemoattractant receptor on human blood monocytes using a new radioligand..
63:588-592.
1984
-
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma..
63:639-648.
1984
-
Specific receptors for phorbol diesters on freshly isolated human myeloid and lymphoid leukemia cells: comparable binding characteristics despite different cellular responses..
63:298-304.
1984
-
Is activation of the granulocyte by concanavalin-A a reversible process?.
63:114-120.
1984
-
Marrow harvesting from normal donors.
64:630-634.
1984
-
Impaired granulocyte superoxide production and prolongation of the respiratory burst due to a low-affinity NADPH-dependent oxidase..
62:564-571.
1983
-
Human neutrophil dysfunction with giant granules and defective activation of the respiratory burst..
61:1247-1257.
1983
-
Studies of T-lymphocytes in preleukemic disorders and acute nonlymphocytic leukemia: in vitro radiosensitivity, mitogenic responsiveness, colony formation, and enumeration of lymphocytic subpopulations..
61:449-455.
1983
-
Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse.
61:949-953.
1983
-
Combined modality therapy of advanced non-Hodgkin's lymphoma: An analysis of remission duration and survival in 95 patients.
62:51-61.
1983
-
Fanconi's anemia treated by allogeneic marrow transplantation.
61:954-959.
1983
-
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: Is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?.
61:672-675.
1983
-
Con-A-stimulated superoxide production by granulocytes: reversible activation of NADPH oxidase..
60:1188-1194.
1982
-
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study)..
60:1159-1168.
1982
-
Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia..
60:856-863.
1982
-
Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates..
60:463-473.
1982
-
Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside..
59:1351-1353.
1982
-
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients..
59:236-246.
1982
-
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies.
60:752-757.
1982
-
Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease.
60:714-720.
1982
-
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease..
59:198-201.
1982
-
Low serum thymic hormone levels in patients with chronic graft-versus-host disease.
59:1073-1075.
1982
-
Opsonized zymosan-stimulated granulocytes-activation and activity of the superoxide-generating system and membrane potential changes..
58:975-982.
1981
-
Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cells..
58:1047-1049.
1981
-
An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre-B leukemia..
58:135-140.
1981
-
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission..
57:798-801.
1981
-
A radioreceptor assay for quantitating plasma factor VIII/von Willebrand's protein..
57:579-585.
1981
-
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems..
57:510-517.
1981
-
Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression.
57:267-276.
1981
-
Effects of quercetin on magnesium-dependent adenosine triphosphatase and the metabolism of human polymorphonuclear leukocytes.
57:561-566.
1981
-
Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.
58:360-368.
1981
-
Distribution of complement receptors on human normal and malignant mononuclear cells..
56:792-797.
1980
-
Chlorpromazine inhibition of granulocyte superoxide production..
56:23-29.
1980
-
Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells..
55:1040-1046.
1980
-
Activation of the guinea pig granulocyte NAD(P)H-dependent superoxide generating enzyme: localization in a plasma membrane enriched particle and kinetics of activation..
55:355-363.
1980
-
Activity and activation of the granulocyte superoxide-generating system..
55:85-92.
1980
-
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma..
54:824-836.
1979
-
Is there a precursive, relatively procoagulant-inactive form of normal antihemophilic factor (factor VIII)?.
54:916-927.
1979
-
Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate..
54:35-45.
1979
-
Second cessation of therapy in childhood lymphocytic leukemia..
53:1114-1120.
1979
-
Arsenic-induced bone marrow toxicity: ultrastructural and electron-probe analysis..
53:820-827.
1979
-
Purification and characterization of papain-solubilized HLA antigens from human platelets..
53:838-850.
1979
-
Hairy cell leukemia: cellular characteristics including surface immunoglobulin dynamics and biosynthesis..
53:764-765.
1979
-
Analysis of late infections in 89 long-term survivors of bone marrow transplantation.
53:720-731.
1979
-
Membrane mechanical properties of ATP-depleted human erythrocytes..
52:499-504.
1978
-
Central nervous system bleeding in hemophiliacs..
51:1179-1188.
1978
-
In vitro kinetics of immunoglobulin synthesis and secretion by nonsecretory human myeloma cells..
50:1031-1038.
1977
-
Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia..
50:671-682.
1977
-
Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment..
49:683-691.
1977
-
NEUTROPHIL PARALYSIS ASSOCIATED WITH CONGENITAL ABSENCE OF A SPECIFIC GLYCOPROTEIN.
50:293-293.
1977
-
Human lymphocyte motility: normal characteristics and anomalous behavior of chronic lymphocytic leukemia cells..
48:717-729.
1976
-
Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma..
48:213-222.
1976
-
The influence of temperature on red cell deformability..
46:611-624.
1975
-
Intranuclear inclusions in Bence Jones lambda plasma cell myeloma..
45:131-139.
1975
-
Complement-independent clearance of IgG-sensitized erythrocytes: inhibition by cortisone..
44:629-637.
1974
-
A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma..
43:493-504.
1974
-
Isoantibody specificity in post-transfusion purpura..
41:817-822.
1973
-
Enzymatic studies in the different types of normal and leukemic human white cells..
18:317-327.
1961
-
Progress with unrelated cord blood transplants in adults.
101:4648-4648.
-
How I use fibrinogen replacement therapy in acquired bleeding..
125:1387-1393.
2015
-
Tackling T-cell tumors.
102:2313-2313.
-
A Phase 2 Study of Actinium-225 (Ac-225)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 mu ci/Kg/Dose
2018
-
Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease
2018
-
Calcium/Calmodulin Dependent Protein Kinase Kinase 2 (CaMKK2) Expressed in the Host Promotes Lymphoma Cells Growth By Controlling Myeloid Derived Suppressor Cells Expansion
2018
-
Disparities in Foundation and Federal Support and Development of New Therapeutics for Sickle Cell Disease and Cystic Fibrosis
2018
-
ET190L1-Artemis (TM) Cell Therapy Results in Durable Disease Remissions with No Cytokine Release Syndrome or Neurotoxicity in Patients with Relapsed and Refractory B-Cell Lymphoma
2018
-
Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Combination with Azacitidine or Daratumumab in Non-APL Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
2018
-
End-of-Life Care Quality Outcomes Among Medicare Beneficiaries with Hematologic Malignancies
2018
-
Health Related Quality of Life and Fatigue in Patients with Pyruvate Kinase Deficiency
2018
-
Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd
2018
-
Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand
2018
-
Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study
2018
-
Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant
2018
-
Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart (R) Molecule for T-Cell Redirected Therapy
2018
-
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
2018
-
Palliative Care Physicians' Views Toward Hematology and the Care of Patients with Hematologic Diseases: Results of a Nationwide Survey
2018
-
Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey
2018
-
Pediatric Patient-Reported Symptom Tracking in Oncology (Pedi-PReSTO): A Feasibility Study
2018
-
Phase 1 Cohort Expansion of Flotetuzumab, a CD123xCD3 Bispecific Dart (R) Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
2018
-
Predictors of Patient-Reported Communication with Their Health Care Team about New Treatment Options for Chronic Lymphocytic Leukemia
2018
-
Rapid and Robust CD4+and CD8+T-, NK-, B- and Monocyte Cell Reconstitution after Nicotinamide-Expanded Cord Blood Transplantation
2018
-
Results of Pivotal Phase 2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2018
-
Sleep Disturbance Among Individuals with Multiple Myeloma: The Interplay between Physical and Psychosocial Symptoms
2018
-
Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study
2018
-
Treatment Decision Making and Treatment Satisfaction Among Individuals Living with Chronic Myeloid Leukemia
2018
-
Treatment with Foscarnet after Allogenic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function
2018
-
Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia
2018
-
Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor - Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts
2018
-
Acute Lymphoblastic Leukemia Cells Bypass the Blood Brain Barrier to Enter the CNS Via a Neuronal Developmental Pathway
2017
-
Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data
2017
-
Beliefs and Patterns of Practice in the Management of Hyperleukocytosis and Leukostasis Among Health Care Providers for Patients with Acute Leukemia: A Large North American Web-Based Survey
2017
-
Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia
2017
-
Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Demonstrate DHRS3 Induction and Myeloid Differentiation Following Sy-1425 Treatment
2017
-
Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens
2017
-
Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow
2017
-
Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs
2017
-
IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia
2017
-
Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)
2017
-
Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study
2017
-
Multiple Myeloma Symptom Burden, Perceived Control, and Quality of Life: Findings from the Cancer Experience Registry
2017
-
Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors
2017
-
Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults
2017
-
Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia
2017
-
Pre-Transfusion Rejuvenation of RBCs for Red Blood Cell Exchange: Report of Feasibility
2017
-
Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study
2017
-
RNA-Sequencing of Isolated Cell Populations Expressing Human APOL1 Risk Variants Reveals Molecular Correlates of Sickle Cell Nephropathy in Zebrafish Podocytes
2017
-
Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib
2017
-
Results from the US Life after Stopping TKIs (LAST) Study
2017
-
Role of Glucose Transporter 1 in Graft-Versus-Host Disease and Graft-Versus-Tumor Effect
2017
-
The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation
2017
-
Transcript Expression, Intron Retention, and RNA Editing Are Conserved in Human Platelets over a 4 Year Period
2017
-
Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia
2017
-
Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices
2017
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in the Emergency Department
2016
-
A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+Acute Leukemia (SWOG 1312)
2016
-
A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
2016
-
A Phase 1b Study of Vadastuximab Talirine As Maintenance and in Combination with Standard Consolidation for Patients with Acute Myeloid Leukemia (AML)
2016
-
A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
2016
-
A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)
2016
-
Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning
2016
-
All-Trans Retinoic Acid (ATRA) Targets IRF4 Deficient, NOTCH2-Activated B Cells from Chronic Gvhd Patients
2016
-
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke (CoBIS): Clinical Outcomes from a Phase 1 Safety Study
2016
-
Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
2016
-
Aptamer Mediated Inhibition of Protein S
2016
-
Cell-Free DNA Is Elevated after Acute Arterial Injury in Infants
2016
-
Clinical Characteristics and Quality of Life of Children with ITP Starting Second Line Treatments: Data from the ITP Consortium of North America ICON1 Study
2016
-
Clinical Characteristics of Hyposecretory Multiple Myeloma (Monoclonal Immunoglobulin < 3 g/dl) in Afro-Caribbean Patients at a Single Urban Institution
2016
-
Comparable Outcomes of Patients Eligible Versus Ineligible for Southwest Oncology Group (SWOG) Leukemia Studies
2016
-
Complete Remissions (CRs) with Azacitidine Regimens Compared to Crs with 7+3 Induction Chemotherapy and the Effect on Overall Survival
2016
-
Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial
2016
-
Current Diagnosis Patterns for Acute Myeloid Leukemia (AML) in Clinical Practice Compared with World Health Organization (WHO) 2008 Recommendations: Outcomes from the CONNECT (R) Myelodysplastic Syndromes (MDS) and AML Disease Registry
2016
-
Durable Overall Survival Benefit in Patients >= 60 Years with Relapsed or Refractory AML Treated with Vosaroxin/Cytarabine Vs Placebo/Cytarabine: Updated Results from the Valor Trial
2016
-
EGF Accelerates Hematopoietic Stem Cell Regeneration Following 5-FU Chemotherapy Via G-CSF Receptor Signaling
2016
-
ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib
2016
-
Effect of FXIII Polymorphism on Formation of Heterocellular Aggregates in SCD
2016
-
Factors Related to the Progression of Sickle Cell Disease Nephropathy
2016
-
Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat
2016
-
Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/ Refractory Acute Myeloid Leukemia (R/R AML)
2016
-
Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents
2016
-
GWAS Meta-Analysis of Glomerular Filtration Rate in Three Cohorts of Sickle Cell Disease Patients and In Vivo Functional Analysis Reveals Potential Nephropathy Candidate Genes
2016
-
Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
2016
-
Improved Prognostic Significance of Genomic and Transcriptional Biomarkers By Examining Enriched Populations of AML Blasts: A SWOG Report
2016
-
Long Term Survival and Clinical Complete Responses of Various Prognostic Subgroups in 103 Relapsed/Refractory Acute Myeloid Leukemia(r/r AML) Patients Treated with Guadecitabine (SGI-110) in Phase 2 Studies
2016
-
Mechanism of Complement Activation By PF4/ Heparin Complexes
2016
-
Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes
2016
-
PCTP (Phosphatidylcholine Transfer Protein) is Regulated By RUNX1 in Platelets/Megakaryocytes and is Associated with Adverse Cardiovascular Events
2016
-
Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP
2016
-
Postoperative Venous Thromboembolism in Children Is Increased in Setting of Cancer or Infection
2016
-
Prospective Implementation of Multi-Disciplinary Obstetric Team Decreases the Mortality Rate of Pregnant Women with Sickle Cell Disease in Ghana
2016
-
RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit
2016
-
Recipient-Derived BAFF and Alloantigen Synergistically Activate B Cells in Murine Chronic Gvhd
2016
-
Results from Ongoing Phase 2 Trial of SL-401 As Consolidation Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission with High Relapse Risk Including Minimal Residual Disease (MRD)
2016
-
Results from Phase 2 Trial Ongoing Expansion Stage of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2016
-
Results of a Clinical Study of Pevonedistat (Pev),a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)
2016
-
Ruxolitinib Used to Treat Hypereosinophilic Syndrome
2016
-
SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA plus V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
2016
-
Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged >= 65 Years with Acute Myeloid Leukemia
2016
-
Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival
2016
-
Simultaneous Measurement of Cerebral Blood Flow and Arterial Transit Time for Sickle Cell Disease
2016
-
Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease
2016
-
Surface CD5 Protein Risk Stratifies Chronic Lymphocytic Leukemia
2016
-
Three Factor Prothrombin Complex Concentrates in Cardiac Surgery: A Novel Algorithmic Approach to Perioperative Bleeding
2016
-
Thrombospondin-1 Polymorphisms Are Associated with Chronic Kidney Disease in Sickle Cell Anemia
2016
-
Toxicities and Related Outcomes of Elderly Patients (pts) (>= 65 Years) with Hematologic Malignancies in the Contemporary Era (Alliance A151611)
2016
-
Transformation in Pre-Treatment Presentations of Gaucher Disease during the First Two Decades of Imiglucerase Enzyme Replacement Therapy: A Report from the International Collaborative Gaucher Group Gaucher Registry
2016
-
Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes
2016
-
Use of Mobile Technology to Monitor Pain and Reduce Outpatient, Emergency Department (ED), and Hospital Visits for Sickle Cell Pain Crisis
2016
-
Vadastuximab Talirine Monotherapy in Older Patients with Treatment Naive CD33-Positive Acute Myeloid Leukemia (AML)
2016
-
Vadastuximab Talirine Plus Hypomethylating Agents: A Well-Tolerated Regimen with High Remission Rate in Frontline Older Patients with Acute Myeloid Leukemia (AML)
2016
-
Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial
2016
-
Von Willebrand Factor to Prevent Postpartum Hemorrhage
2016
-
A Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Adults with Relapsed or Refractory Leukemia: Safety, Clinical Activity, Exposure and Target Inhibition
2015
-
A Phase 1 Trial of SGN-CD33A As Monotherapy in Patients with CD33-Positive Acute Myeloid Leukemia (AML)
2015
-
A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma.
2015
-
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies
2015
-
AAV Gene Therapy for MPS1 Corneal Clouding and Joint Stiffness
2015
-
Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117
2015
-
Antileukemic Activity and Tolerability of ASP2215 80mg and Greater in FLT3 Mutation-Positive Subjects with Relapsed or Refractory Acute Myeloid Leukemia: Results from a Phase 1/2, Open-Label, Dose-Escalation/Dose-Response Study
2015
-
Autologous Cord Blood Infusion for the Treatment of Brain Injury in Children with Cerebral Palsy
2015
-
Baseline Predictors of Mortality in Patients with Relapsed or Refractory Acute Myeloid Leukemia Treated with Vosaroxin Plus Cytarabine or Placebo Plus Cytarabine in the Phase 3 VALOR Study
2015
-
Characterization of Human and Murine Anti-Protamine/Heparin Antibodies
2015
-
Cord Blood Unit Cryopreservation: Positioning Segments for Potency Assessment
2015
-
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial
2015
-
Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106
2015
-
Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma
2015
-
Dickkopf 1 (Dkk1) Regulates Hematopoietic Stem Cell Regeneration
2015
-
ENESTnext Final Results: Deep Molecular Response (MR) with Nilotinib (NIL) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
2015
-
Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi Institutional Review
2015
-
Effect of Minimal Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia
2015
-
Functional Analysis of the CML Blast Crisis Transcriptome and Epigenome Using Crispr-CAS9 and Pharmacologic Approaches
2015
-
Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy
2015
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell (HSC) Self-Renewal Via Control of mTOR Signaling
2015
-
Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone
2015
-
Impact of Available Therapies on Survival of Very Elderly Myelodysplastic Syndrome (MDS) Patients (Age above 75 yrs)
2015
-
Impact of GvHD and Other Patient-, Disease-, Donor and Transplantation-Related Factors on 5 Year Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission
2015
-
Lead-in Stage Results of a Pivotal Trial of SL-401, an Interleukin-3 Receptor (IL-3R) Targeting Biologic, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) or Acute Myeloid Leukemia (AML)
2015
-
Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)
2015
-
Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants
2015
-
Multi-Center US Intergroup Study of Intensive Chemotherapy Plus Dasatinib Followed By Allogeneic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60
2015
-
Multiple Myeloma Patient Experience with Financial Toxicity: Findings from the Cancer Experience Registry
2015
-
North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia
2015
-
Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit
2015
-
Potentially Avoidable Hospitalizations in Older Patients with Acute Myeloid Leukemia (AML)
2015
-
Prognostic Methylation Markers for Survival in Cytogenetically Normal AML Patients Treated on SWOG Trials
2015
-
Prothrombin Complex Concentrates and Cardiac Surgery
2015
-
Rapid Achievement of MR4.5 after Switching from Imatinib (IM) to Nilotinib (NIL) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Preliminary Results from ENESTgoal
2015
-
Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306
2015
-
Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia
2015
-
Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE)
2015
-
Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
2015
-
SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML
2015
-
Symptom Burden, Quality of Life, and Distress in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy: Results of a Prospective Electronic Patient-Reported Outcomes Study
2015
-
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia
2015
-
Targeting the Human Notch 2-BCR Axis: A Driver of B-Cell Hyper-Responsiveness in Active Chronic Graft-Versus Host Disease (cGVHD)
2015
-
The Genomic and Epigenomic Landscapes of Blast Crisis Transformation in Chronic Myeloid Leukemia
2015
-
The Phenotypic Spectrum of Pyruvate Kinase Deficiency (PKD) from the PKD Natural History Study (NHS): Description of Four Severity Groups By Anemia Status
2015
-
The Spectrum of Alpha-Spectrin Associated Hereditary Spherocytosis
2015
-
The Thrombotic Microangiopathy Registry of North America
2015
-
Thrombocytopenia in Hospitalized Non-ICU Patients
2015
-
beta-arrestin2 Is Necessary for Development of MPLW515L Mutant Primary Myelofibrosis
2015
-
A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117
2014
-
Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation
2014
-
Atomic Level Description of the Immune Complex That Causes Heparin-Induced Thrombocytopenia (HIT)
2014
-
Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease
2014
-
Biologic Activities of Protamine/Heparin Antibodies
2014
-
Broncho-Alveolar Lavage and Lung Biopsy in Patients with Hematological Malignancy and Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review and Meta-Analysis
2014
-
Calcium Calmodulin Dependent Kinase Kinase 2 Regulates Hematopoietic Stem Cell Regeneration and Quiescence
2014
-
Clinician Approaches to Myeloma in Academia and the Community : An in-Practice Qualitative Study
2014
-
Deep Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
2014
-
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
2014
-
Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia
2014
-
Effects of Sulforaphane Obtained from Broccoli Sprout Homogenate in Patients with Sickle Cell Disease (SCD)
2014
-
Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG
2014
-
Epigenetics of Cellular Memory: Insights from the Chromatin Accessibility Landscape of the Mitotic Genome
2014
-
Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model
2014
-
Favorable Outcomes for Older Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early Results of US Intergroup Trial C10403
2014
-
Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
2014
-
Genes Associated with Alloimmunization to Blood Group Antigens in Sickle Cell Disease
2014
-
Genes Associated with Survival in Adult Sickle Cell Disease
2014
-
Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients
2014
-
Growing Pains - Determination of Transfer and Transition from Pediatrics to Adult Outpatient Clinics for Patients with Sickle Cell Disease (SCD)
2014
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell Renewal
2014
-
Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)
2014
-
Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML)
2014
-
Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer
2014
-
Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis
2014
-
Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 Trial
2014
-
Phase II study of (90)y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma
2014
-
Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience
2014
-
Predicting the Temporal Course of Laboratory Abnormality Resolution in Patients with Thrombotic Microangiopathy
2014
-
Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope (TM)): Case Matched Analysis
2014
-
Protein Tyrosine Phosphatase-Sigma (PTP sigma) Regulates Hematopoietic Stem Cell Repopulating Capacity
2014
-
Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease
2014
-
The CRM1 Nuclear Export Receptor Activates HOXA Gene Expression in Leukemogenesis
2014
-
Understanding the Underlying Immune Response in HIT: Uptake of PF4/Heparin Complexes By Monocytes & Dendritic Cells
2014
-
X-Ray Structure of an Anticoagulant RNA Aptamer Bound to Factor Xa. Structural Basis for Its Ability to Disrupt Interactions Between Xa and Va within Prothrombinase
2014
-
Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.
2014
-
Alteration Of Cytogenetic Risk Stratification In New Diagnosis Of Leukemia By FISH Testing - Retrospective Review Of The SWOG Experience
2013
-
Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study
2013
-
Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population
2013
-
Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease
2013
-
Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance)
2013
-
GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease
2013
-
Humoral Immunity Induced By Viral Infection Provides a Major Barrier To Hematopoietic Cell Transplantation
2013
-
In Vivo Modeling Of Genetic Mechanisms Associated With Sickle Cell Disease Nephropathy
2013
-
MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study
2013
-
Molecular and Clinical Associations Between Vitamin D and Chronic Lymphocytic Leukemia
2013
-
Nentropenia In Glycogen Storage Disease 1b (GSD1b)
2013
-
OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias
2013
-
Palliative Care For Patients With Hematologic Malignancies: A Profile Of Patients With Blood Cancers Referred To The Choice Hospice Network
2013
-
Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) plus Rituximab +/- Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas
2013
-
Recruitment Of T Cells and Macrophages To The Eyes In Recipients Of Allogeneic Hematopoietic Stem Cell Transplants Correlate With Inflamatory Cytokine Presence In Ocular Gvhd
2013
-
Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo
2013
-
PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma.
2013
-
A Genome-Wide Analysis of Variants Influencing Methotrexate Clearance Replicates SLCO1B1
2012
-
A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)
2012
-
A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline
2012
-
A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients
2012
-
Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes
2012
-
Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes
2012
-
An Institutional Experience: Correlation Between Absolute Lymphocyte Count and Survival Outcome After Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
2012
-
CD38 Variation in Chronic Lymphocytic Leukemia
2012
-
Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given "Intensive" Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA)
2012
-
Describing Adherence to Recommended Preventative Care Behaviors Among Adults with Sickle Cell Disease
2012
-
Feasibility and Prognostic Value of VO2(peak) in Patients Undergoing Hematopoietic Cell Transplantation (HCT)
2012
-
Feasibility and Prognostic Value of VO2(peak) in Patients Undergoing Hematopoietic Cell Transplantation (HCT)
2012
-
Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)
2012
-
Genetic Loss of Tmprss6 Increases Effective Erythropoiesis in a Mouse Model of beta-Thalassemia
2012
-
Genetic Loss of Tmprss6 Increases Effective Erythropoiesis in a Mouse Model of beta-Thalassemia
2012
-
Genome-Wide Association Study Identifies Germline Polymorphisms Associated with Relapse of Childhood Acute Lymphoblastic Leukemia
2012
-
Genome-Wide Association Study Identifies a Novel Susceptibility Locus At 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethinically Diverse Populations
2012
-
High Incidence of Antibodies to Protamine and Protamine/Heparin Complexes in Patients Undergoing Cardiopulmonary Bypass
2012
-
High Incidence of Antibodies to Protamine and Protamine/Heparin Complexes in Patients Undergoing Cardiopulmonary Bypass
2012
-
ID3 Is a Novel Tumor Suppressor Gene in Burkitt Lymphom
2012
-
Incidence, Treatment, and Consequences of Chemotherapy-Induced Febrile Neutropenia in Inpatient and Outpatient Settings
2012
-
Iron Deprivation Impairs Proliferation of CALM-AF10 leukemia Cells in Vitro and in Vivo
2012
-
Iron Deprivation Impairs Proliferation of CALM-AF10 leukemia Cells in Vitro and in Vivo
2012
-
Long Term Outcomes of Hematopoietic Stem Cell Transplantation in Patients with Severe Phenotype Hurler Syndrome: an International Multi-Center Study
2012
-
Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria
2012
-
Modeling Variation in the Human Lymphoma Microenvironment with the E mu-Myc Mouse Model
2012
-
No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial
2012
-
No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial
2012
-
Novel Techniques for Measurement of Variable Sized PF4/H Complexes
2012
-
Outcome of Transplantation for Acute Leukemia in Down Syndrome
2012
-
PF4/H Complexes Induce Germinal Centers in Vivo
2012
-
Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State
2012
-
Partial Reversal of Dabigatran Effect by a Prothrombin Complex Concentrate in a Model of Thrombin Generation
2012
-
Partial Reversal of Dabigatran Effect by a Prothrombin Complex Concentrate in a Model of Thrombin Generation
2012
-
Peripheral Blood gamma delta T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy
2012
-
Peripheral Blood gamma delta T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy
2012
-
Phase 1 Study of Lenalidomide and Decitabine for High and Intermediate 2 Risk MDS
2012
-
Phase II Study of VEGF Inhibitor, PTK787/ZK222584, in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma
2012
-
Pilot Study of Sorafenib for Myelodysplastic Syndrome
2012
-
Polycythemia Vera and Chronic Idiopathic Myelofibrosis CD34+Cells Preferentially Traffic to Splenic Niches
2012
-
Proteomic Analysis of ERK1/2-Mediated Human Sickle Red Blood Cell Membrane Protein Phosphorylation
2012
-
Results From the Dose Escalation Phase of a Randomized Phase 1-2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapsed/Refractory MDS and AML
2012
-
Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results of a Treatment IND (T-IND) Expanded Access Protocol
2012
-
SL-401, A Targeted Therapy Directed to the Interleukin-3 Receptor Present On Leukemia Blasts and Cancer Stem Cells, Is Active As a Single Agent in Patients with Advanced AML
2012
-
Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation
2012
-
Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation
2012
-
The Metabolic Signature of CLL: Enhanced Glucose Metabolism in A Subset of High-Risk CLL Patients
2012
-
Therapeutic Benefit of Small Molecule Inhibitors of MEK/ERK in Reducing Sickle Red Cell Adhesion and Vaso-Occlusion in Vivo
2012
-
Therapeutic Benefit of Small Molecule Inhibitors of MEK/ERK in Reducing Sickle Red Cell Adhesion and Vaso-Occlusion in Vivo
2012
-
Timing of the Initiation of Hydroxyurea and Hematologic Outcomes in Patients with Sickle Cell Disease (SCD)
2012
-
Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma
2012
-
Using High-Throughput Sequencing of Red Blood Cells and Platelets to Identify Micrornas Associated with Hematopoiesis.
2012
-
A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia
2011
-
A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABL(T315I) Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors
2011
-
A Phase II Prospective Feasibility Study of Clofarabine Cytoreduction Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed or Refractory Acute Leukemias and Advanced Myelodysplastic Syndromes
2011
-
A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline, and Evaluation of the Impact of the Nucleoside Transporter hENT1 on Response
2011
-
ASXL1 Mutations Identify a High-Risk Subgroup of Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia within the European LeukemiaNet 'Favorable' Genetic Category
2011
-
An Elevated Tricuspid Regurgitant Jet Velocity in Sickle Cell Disease Is Associated with Polymorphisms in Genes Impacting Innate Immunity
2011
-
Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease
2011
-
CALM Insufficiency Impairs Leukemia Cell Proliferation by Limiting Iron Uptake
2011
-
CPX-351: A Randomized Phase 2b Study of CPX-351 v. Intensive Salvage Therapy in '65 Yo First Relapse AML Patients: Initial Efficacy and Safety Report
2011
-
Characterization of Pim Protein Kinases and Evaluation of Small Molecule Inhibitors in Multiple Myeloma
2011
-
Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost
2011
-
Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells
2011
-
Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol
2011
-
Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends
2011
-
Genomic Heterogeneity in B-Cell Malignancies
2011
-
HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery
2011
-
High Complete Response Rates with Dose Dense/Dose Intense Chemotherapy Plus Radioimmunotherapy in High Risk Diffuse Large B Cell and Mantle Cell Lymphoma
2011
-
High Dose BCNU/Melphalan Preparative Regimen Doubles Event Free Survival of Myeloma Patients Undergoing Autologous Transplantation
2011
-
Hijacking the Niche: The Role of Stromal Osteopontin in the Induction of Leukemic Dormancy within the Bone Marrow Microenvironment
2011
-
Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma
2011
-
Inflammatory Polymorphisms Link the Risk of Acute Chest Syndrome with Asthma in Adults with Sickle Cell Disease
2011
-
MiR-3151, a Novel MicroRNA Embedded in BAALC, Is Only Weakly Co-Expressed with Its Host Gene and Independently Impacts on the Clinical Outcome of Older Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
2011
-
Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures
2011
-
Prevalence of MBL Increases Over Time In Relatives of CLL Families
2011
-
Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18-60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG
2011
-
Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)
2011
-
Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia
2011
-
Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia
2011
-
Referral Patterns and Outcomes for Women with for Recurrent Pregnancy Loss Managed At a Multidisciplinary Thrombosis Program
2011
-
Relationships Among Commonly Used Measures of Cord Blood Potency, ALDH(br) Cell Content, and Colony Forming Cell Content in Cord Blood Units Prior to Cryopreservation: Towards An Improved Metric for Potency of Banked Cord Blood
2011
-
Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia
2011
-
Safety and Tolerability of Plerixafor in Combination with Cytarabine and Daunorubicin in Patients with Newly Diagnosed Acute Myeloid Leukemia-Preliminary Results From a Phase I Study
2011
-
Sickle Red Blood Cell Induced Adhesion of Neutrophils to Endothelial Cells and Biologic Correlates of Leukocyte Activation
2011
-
Significance of Prior HSCT on the Outcome of Salvage Therapy with CPX-351 or Conventional Chemotherapy Among First Relapse AML Patients
2011
-
Sirolimus Inhibits Proliferation but Enhances Suppressive Activity of Rhesus Macaque Natural CD4 Regulatory T Cells
2011
-
The Impact of Factor IX Level on Thrombin Generation and Bleeding During Warfarin Anticoagulation
2011
-
The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation
2011
-
The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome
2011
-
Transient Decrease in Factor VIII Following Delivery: Clearance or Consumption?
2011
-
What Clinical Characteristics of Mothers and Babies Favorably Influence Cord Blood Potency? Defining Parameters That Can Guide Public Cord Blood Collection
2011
-
Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma
2011
-
Whole-Exome Sequencing Identifies Novel Risk Variant for Thrombotic Storm
2011
-
A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study
2010
-
A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation
2010
-
A Novel Scoring System, the Cord Blood Apgar, Predicts Engraftment After Cord Blood Transplantation: Optimization of Selection of Cord Blood Units (CBUs) for Transplantation
2010
-
A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies
2010
-
A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease
2010
-
A Retrospective Multi-Center Analysis of Prognostic Factors Determining Outcomes In Patients with Secondary AML.
2010
-
ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
2010
-
Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan x 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML
2010
-
Alternative Splicing Is a Major Mechanism of Gene Regulation In Diffuse Large B Cell Lymphoma
2010
-
Analysis of Risk Factors Influencing Outcomes After Unrelated Cord Blood Transplantation In Children with Juvenile Myelomonocytic Leukemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study
2010
-
Anti-Inflammatory Markers Are Associated with Glomerular Filtration Rate In Adults with Sickle Cell Disease
2010
-
Atypical Activation of Plasma Membrane-Bound ERK1/2 Is Associated with Regulation of Sickle Red Cell Adhesion to Endothelium
2010
-
Chronic Graft-Versus-Host Disease and Its Association with Treatment-Related Mortality, Relapse, Leukemia-Free and Overall Survival After Umbilical Cord Blood Transplantation (UCBT) In Children and Adolescents with Acute Leukemia
2010
-
Complications of Implantable Venous Access Devices In Patients with Sickle Cell Disease
2010
-
Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol
2010
-
Dendritic Cell Activation by PF4/H Multimolecular Complexes
2010
-
Disruption of PF4/Hep Multimolecular Complex Assembly Using a Minimally Anticoagulant Heparin (ODSH)
2010
-
Donor Cell Leukemia: A Clinicopathological Study of 9 Cases and a Comprehensive Review of Literature
2010
-
Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil (R)) plus G-CSF In Adult Patients with Non-Hematologic Malignancies.
2010
-
Efficacy and Toxicity of Rituximab and Brief Duration, High Intensity Chemotherapy with Filgrastim Support for Burkitt or Burkitt - Like Leukemia/Lymphoma: Cancer and Leukemia Group B (Calgb) Study 10002
2010
-
Efficacy of Denileukin Diftitox Retreatment In Patients with Cutaneous T-Cell Lymphoma Who Relapsed After Initial Response
2010
-
Facilitation of Hematopoietic Reconstitution Via Inhibition of Bone Marrow Endothelial Cell-Mediated SDF-1 Signaling
2010
-
Factors Associated with Heterocellular Aggregate Formation In Sickle Cell Disease.
2010
-
GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease.
2010
-
Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy
2010
-
Heparin Modifies the Immunogenicity of Positively-Charged Proteins
2010
-
Hepcidin as a Therapeutic Tool to Limit Iron Overload and Improve Anemia In beta-Thalassemia
2010
-
Hydroxyurea Induces Genome-Wide Epigenetic Changes In Sickle Cell Disease.
2010
-
Hydroxyurea Reduces Conversion From Conditional to Abnormal TCD Velocities In Children with Sickle Cell Anemia (SCA)
2010
-
Identification of Thrombospondin-1 and L-Selectin as Potential Plasma Biomarkers of Silent Cerebral Infarct In Children with Sickle Cell Disease Using a Proteomic-Based Approach
2010
-
Identification of a Costimulation Blockade Resistant Mechanism of Bone Marrow Allograft Rejection Induced by Infection with a Murine EBV Homologue.
2010
-
Increased Platelet Binding of NN1731, a Factor VIIa Variant with Enhanced Tissue Factor-Independent Activity
2010
-
Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes
2010
-
Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci
2010
-
Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning
2010
-
Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC)
2010
-
Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study
2010
-
Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results
2010
-
Phase I Trial Results for SL-401, a Novel Cancer Stem Cell (CSC) Targeting Agent, Demonstrate Clinical Efficacy at Tolerable Doses In Patients with Heavily Pre-Treated AML, Poor Risk Elderly AML, and High Risk MDS
2010
-
Pleiotrophin Signaling Is Necessary and Sufficient for Hematopoietic Stem Cell Self-Renewal In Vivo
2010
-
Post-Transplant Lymphoproliferative Disease In Liver Transplant Recipients: A Single Institution Experience
2010
-
Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
2010
-
Pregnancy In Type 1 Von Willebrand Disease: A Prospective Study of VWF Levels and Risk Factors for Bleeding.
2010
-
Prolonged Administration of Azacitidine with or without Entinostat Increases Rate of Hematologic Normalization for Myelodysplastic Syndrome and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
2010
-
Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies.
2010
-
Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd.
2010
-
Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation
2010
-
Relationship of Soluble Adhesion Receptors to Red Cell Apoptosis In SCD
2010
-
Resource Use and Expenditures Among Adult Sickle Cell Patients with and without Depression.
2010
-
S-Nitrosylation of Rap1and Relationship to Rap1 Activity and Disease Status In SCD
2010
-
Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa.
2010
-
Targeting Destruction of Mcl-1 by Activation of Protein Phosphatase 2A In CLL and B-Cell Lymphomas
2010
-
The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study
2010
-
The Serine Protease Tmprss6 Regulates Hepcidin Expression, but Its Loss Does Not Cause Systemic Iron Deficiency In the Fetal and Neonatal Periods
2010
-
Tmprss6, An Inhibitor of Hepatic Bmp/Smad Signaling, Is Required for Hepcidin Suppression and Iron Loading In a Mouse Model of beta-Thalassemia
2010
-
Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing-Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis
2010
-
VE Cadherin Positive Endothelial Cells Regulate Hematopoietic Reconstitution In Vivo
2010
-
Validation of the Cord Blood (CB) APGAR Score System to Predict Neutrophil Engraftment of Plasma Depleted CB Products
2010
-
A Comprehensive Identification of the Microrna Transcriptome and Its Application in B Cell Malignancies
2009
-
A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
2009
-
A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.
2009
-
ALDH(br) Hematopoietic Progenitors Promote Short-Term Engraftment in Experimental Models for Cord Blood Transplantation.
2009
-
Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.
2009
-
Cenersen, An Antisense Inhibitor of p53, in Combination with Fludarabine, Cyclophosphamide, and Rituximab Shows Clinical Activity in High Risk CLL.
2009
-
Characterization of Receptors Involved in Heparin Antibody Complex Mediated Induction of Tissue Factor Expression in Monocytes
2009
-
Comparison of Thrombin Generation of Sickle Cell Patients in Microparticle Rich and Microparticle Poor Plasma Using Thrombin Generation Assay (TGA).
2009
-
Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors
2009
-
Creation of a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Cord Blood Potency.
2009
-
Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control
2009
-
Deletion of Bak and Bax in Tie2+BM Hematopoietic Stem Cells Induces a B Cell Lymphoproliferative Disorder
2009
-
Development of a Decision Support Tool to Guide Management of Adults with Sickle Cell Disease: The Emergency Department Sickle Cell Assessment of Strengths and Needs (ED-SCANS).
2009
-
Effect of PAI-1 Specific RNA Aptamers On Cell Adhesion and Motility
2009
-
Effects of Hydroxyurea (HU) and Magnesium Pidolate (Mg) in Hemoglobin SC Disease (HbSC): the "CHAMPS" Trial
2009
-
Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study
2009
-
Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology
2009
-
Genetic Polymorphisms in NEDD4L Are Associated with Pulmonary Hypertension of Sickle Cell Anemia.
2009
-
Genome-Wide Analysis of Microdeletions and Identification of NF1 Inactivation in Acute Myelogenous Leukemia.
2009
-
Genome-Wide Studies in Sickle Cell Anemia Show Associations Between SNPs in the Olfactory Receptor Gene Cluster and Fetal Hemoglobin Concentration
2009
-
Heparin Forms Macromolecular Complexes with Protamine and Lysozyme.
2009
-
Histone Deacetylase Inhibition Using LBH589 Is Effective in Lymphoma and Results in Down-Regulation of the NF-KB Pathway
2009
-
Immunocompromised Status of Patients with Hematologic and Solid Tumor Malignancies: Construction of a Practical Algorithm
2009
-
Impact of Nucleated Cell Dose On Engraftment and Survival After Unrelated Cord Blood Transplantation for Severe Aplastic Anemia: A Retrospective Study On Behalf of Eurocord and the EBMT SAA WP
2009
-
Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Sub-Analyses of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study
2009
-
In-Hospital Outcomes Among Sickle Cell Patients with Acute Chest Syndrome: Results From a National Database.
2009
-
Increased Severity of Pandemic H1N1 Influenza in Children and Young Adults with Sickle Cell Disease
2009
-
Influence of Statin Therapy On the Clinical Course of Chronic Lymphocytic Leukemia
2009
-
Long-Term Survival and Late Deaths After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism
2009
-
Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT)
2009
-
Low Levels of Apolipoprotein A1 Are Associated with Silent Cerebral Infarets in Children with Sickle Cell Disease
2009
-
Maintenance Therapy with Low-Dose Subcutaneous 5-Azacitidine in Older Patients with AML in 1st Remission.
2009
-
Molecular Profiling Identifies Plasmablasts as the Cells of Origin of Activated Diffuse Large B Cell Lymphoma
2009
-
Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy
2009
-
Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials)
2009
-
Overexpression and Phosphorylation of eIF4E Is Required for Beta-Catenin Activation in Blast Crisis Chronic Myelogenous Leukemia
2009
-
PI3K Inhibitors Inhibit Lymphoma Growth by Downregulation of MYC-Dependent Proliferation.
2009
-
Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.
2009
-
Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML)
2009
-
Physiologic Hypoxia Protects Chronic Myelogenous Leukemia Progenitors From Elimination by Imatinib Mesylate
2009
-
Polymorphisms in TNF alpha Are Associated with Cerebrovascular Events in Sickle Cell Disease.
2009
-
Pralatrexate Induces Responses in Patients with Highly Refractory Peripheral T-Cell Lymphoma (PTCL).
2009
-
Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia
2009
-
Prevention of Acute GvHD During MHC Haploidentical BMT: Evaluating the Efficacy of T-Cell Costimulation Blockade Using a Novel Rhesus Macaque Transplant Model.
2009
-
Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease
2009
-
Racial Differences in Thrombotic Risk Factors Associated with Adverse Pregnancy Outcome Among Women Obtaining Care in US Thrombosis and Hemostasis Centers
2009
-
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
2009
-
Retrospective Review of the Natural History of Pulmonary Hypertension in Sickle Cell Disease Demonstrates That Progressive Enlargement of the Left Atrium Is a Strong Predictor of Death.
2009
-
Single-Agent Clofarabine Produces Durable Remissions in Patients with Acute Myelogenous Leukemia (AML) Who Are >= 70, Have Intermediate or Unfavorable Cytogenetics, Antecedent Hematological Disorders (AHD), or 2 or More Unfavorable Prognostic Factors
2009
-
Systemic Administration of Pleiotrophin Induces Hematopoietic Stem Cell Regeneration In Vivo
2009
-
The Anti-Inflammatory Investigational Agent LMP-420 Demonstrates in Vitro Cytotoxic Activity against Chronic Lymphocytic Leukemia Cells
2009
-
The Complex Relationship Between Sickle Cell Disease and Depression
2009
-
The SET Oncogene, a Potent PP2A Inhibitor, Is Elevated in CLL and Antagonism of SET Induces Apoptosis
2009
-
Thymic Recovery and De Novo T Cell Production During the First Year After Unrelated Cord Blood Transplant (UCBT) Predicts Overall Survival: A Multivariate Analysis of 93 Patients Following Myeloablative Conditioning and a Single Unit Graft.
2009
-
Tie2+Bone Marrow Endothelial Cells Regulate Hematopoietic Reconstitution In Vivo
2009
-
Tmprss6 Is a Genetic Modifier of the Hfe-Hemochromatosis Phenotype in Mice
2009
-
Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources
2009
-
Use of Aldehyde Dehydrogenase Content to Predict Dominating Cord in Double Cord Blood Transplant
2009
-
Use of a Computer Based Neurocognitive Software Program in Asymptomatic Neurologically Intact Adults with Sickle Cell Disease.
2009
-
Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study
2008
-
Comprehensive Ultra High Resolution Analysis of Copy Number and Allele Status Including Novel Microdeletions Spanning NF1 in Acute Myelogenous Leukemia
2008
-
Durable Responses in Patients Treated with Galiximab (Anti-CD80) in Combination with Rituximab for Relapsed or Refractory Follicular Lymphoma: Long-Term Follow-up of a Phase II Clinical Trial.
2008
-
Identification of p53 Aberration-Dependent as Well as Non-p53-Mediated Resistance to MDM2 Inhibitors in Acute Myelogenous Leukemia
2008
-
Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML
2008
-
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy
2008
-
Prevention of Acute GvHD during Haplo-BMT: Evaluating the Efficacy of T-Cell Costimulation Blockade Using a Novel Rhesus Macaque Transplant Model
2008
-
Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients
2008
-
Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study
2008
-
A genomic strategy to refine prognosis and predict response to therapy in chronic lymphocytic leukemia.
2007
-
Analysis of the cellular components of the graft and clinical characteristics of 159 children with lysosomal and peroxisomal disorders (LSD) undergoing unrelated umbilical cord blood transplantation at a single center
2007
-
Apolipoprotein E (APOE) genotype as a determinant of survival in women with chronic lymphocytic leukemia
2007
-
Avoidance of post-thaw wash prior to transplantation of plasma depleted cord blood (PD CB) is associated with improved engraftment & decreased severity of chronic GvHD (cGvHD) without increased relapse
2007
-
Blocking adhesion of sickle erythrocytes to endothelial P-selectin using an RNAaptamer
2007
-
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
2007
-
Cytotoxicity of the type 4 phosphodiesterase inhibitor CD160130 for freshly isolated human CLL cells in vitro
2007
-
Dynamic in vivo imaging reveals that leukemia-induced changes in the bone marrow microenvironment alter mechanisms of metastasis
2007
-
Efficacy of hydroxyurea to prevent organ damage in young children with sickle cell anemia
2007
-
Functional and numerical T cell abnormalities in chronic lymphocytic leukemia
2007
-
Further investigation of the role of factor XIII in priapism associated with SCD
2007
-
Genomic complexity identifies patients with agressive chronic lymphocytic leukemia.
2007
-
Inhibition of nitric oxide synthase (NOS) 1, NOS2, and NOS3 enzymatic activities by vitamin B-12 and related corrins: Biochemical and molecular modeling studies
2007
-
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14 with differential expression of LATS2
2007
-
Monoclonal B cell lymphocytosis as a marker of inherited predisposition to chronic lymphocytic leukemia.
2007
-
Monoclonal B cell lymphocytosis exhibits biologic diversity similar to chronic lymphocytic leukemia
2007
-
Phase I study demonstrates activity and tolerability of diphtheria toxin interleukin-3 fusion protein in patients with AML and MDS
2007
-
Phase II studies of different schedules and doses of the farnesyl transferase inhibitor tipifarnib (R115777, zarnestra, NSC-702818) for patients of age 70 or older with previously untreated acute myeloid leukemia (AML): A north American intergroup study (S0432)
2007
-
Post thaw colony forming units (CFU) is a strong independent predictor of engraftment after unrelated donor umbilical cord blood transplantation (UCBT)
2007
-
Post transplant autoimmune hemolytic anemia and other cytopenias are increased in very young babies after unrelated donor umbilical cord blood transplantation
2007
-
Prediction of heparin induced thrombocytopenia: Validation of an experience-based computer model
2007
-
Predictors of in-hospital mortality and charges in sickle cell disease: Results from the California Discharge Databases 1998-2005
2007
-
Risk factor analysis of outcomes after unrelated cord blood transplantation for children with Hurler's syndrome. An Eurocord-Duke University Collaborative Study
2007
-
Sickle RBCs stimulate human monocyte cytokine expression
2007
-
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-incluced mobilization
2007
-
The effects of chronic opiates pain therapy in sickle cell anemia
2007
-
The relationship of opiate analgesia to quality of life in an adult sickle cell population
2007
-
Use of mesenchymal stem cells to treat pediatric patients with severe (Grade III-IV) acute graft versus host disease refractory to steroid and other agents on a compassionate use basis
2007
-
A phase I study of cloretazine (R) and temozolomide in patients with hematologic malignancies.
2006
-
A phase II trial of combination therapy with arsenic trioxide (ATO) and gemtuzumab ozogamicin (GO) in patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) arising from MDS.
2006
-
Acute graft versus host disease (GVHD) is increased in patients receiving cyclosporine/celicept as frontline prophylaxis against GVKD in pediatric patients undergoing allogeneic stem cell transplantation.
2006
-
Antiproliferative activity of ELACYT (TM) (CP-4055) in combination with cloretazine (VNP40101M), idarubicin or gemcitabine in HL-60 human myeloid leukemia cells.
2006
-
Changes in the pattern of cytogenetic aberrations with advancing age in acute myeloid (Non-APL) leukemia: A Southwest Oncology study (S9007).
2006
-
Coagulopathy from severe postpartum hemorrhage.
2006
-
Cost-effectiveness of posaconazole versus standard azole therapy in the prevention of invasive fungal infections among high-risk neutropenic patients in the US
2006
-
Current prevalence of specific clinical outcomes in adult patients with HbSS or Hb S beta(0) thalassemia.
2006
-
DEAH-box splicing factor gene, prp16 amplification in acute myeloid leukemia.
2006
-
Defects in E2F1/2 expression are associated with abnormalities in cell cycle and differentiation in EKLF-deficient erythroid cells.
2006
-
Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.
2006
-
Determinants of PF4/heparin immunogenicity in a murine model of HIT.
2006
-
Dosing of post-thaw colony forming units (CFU) and CD34 cells predict engraftment and survival in recipients of banked unrelated donor umbilical cord blood (UCB) for allogeneic transplantation.
2006
-
Effect of single dose in vivo propranolol therapy on in vitro adhesion of human SS RBC.
2006
-
Evidence for an adaptive immune barrier after in utero, hematopoietic cell transplantation.
2006
-
Gene expression patterns identify patients with non-small cell lung cancer (NSCLC) and ovarian cancer who are at increased risk for venous thromboembolism (VTE).
2006
-
Genomic profiling of chronic lymphocytic leukemia identifies novel genetic subtypes.
2006
-
Immuno-chemotherapy (IC) and autologous stem cell transplant (ASCT) for untreated patients (pts) with mantle cell lymphoma (MCL): CALGB 59909.
2006
-
Impaired maturation and survival of T lymphocytes, B lymphocytes, and NK cells in mice lacking Gimap5/Ian5.
2006
-
Inhibition of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-ALL after blocking remote 3'-BCL11B enhancer sequences with matching DNA oligos reveals coregulation by PU.1 and HMGA1.
2006
-
Interaction of activated sickle red cell LW with leukocytes induces leukocyte adhesion to endothelium via CD44-E-selectin.
2006
-
MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL.
2006
-
MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL.
2006
-
Mechanism of soluble laminin-mediated enhancement of sickle red cell adhesion to endothelial cells.
2006
-
Melphalan containing cytoreduction results in a good overall survival (OS) in pediatric patients with relapse or refractory AML undergoing unrelated umbilical cord blood transplantation (UCBT).
2006
-
Multivariate analysis of patient and graft specific factors among 330 recipients of unrelated cord blood transplant (UCBT) to predict risk of death from opportunistic infections in the first 6 months after UCBT.
2006
-
Preliminary results of a pilot trial of unrelated umbilical cord blood transplantation (UCBT) augmented with cytolkine-primed aldehyde dehydrogenase-bright (ALDHbr) cells.
2006
-
Prognostic significance of minimal residual disease (MRD) in childhood B-precursor ALL and its relation to other risk factors. A Children's Oncology Group (COG) study.
2006
-
Prospective analysis of TEL and MLL gene rearrangements in childhood acute lymphoblastic leukemia: A Children's Oncology Group study.
2006
-
Restoring initial thrombin generation does not normalize cutaneous wound healingin hemophilia B.
2006
-
Role of erythropoietin as an angiogenic factor and target in cancer.
2006
-
Testicular relapse in lesser, standard, and high risk patients treated with frontline therapy for childhood ALL. Pediatric oncology group protocols 9201, 9405, 9605, and 9406.
2006
-
Tissue factor is absent from sites of cutaneous wounds: Implications for bleeding in hemophilia.
2006
-
Unrelated donor hematopoietic stem cell transplantation (HSCT) in children with acute leukemia: Risks and benefits of umbilical cord blood (CB) versus HLAA, B, C, DRB1 allele-matched bone marrow (BM).
2006
-
Updated cost-effectiveness analysis of first-line imatinib compared to interferon-alpha in patients with newly diagnosed chronic myeloid leukemia in the chronic phase using 60-month data from IRIS.
2006
-
A differentiation block in erythroid cells lacking erythroid krupple-like factor (EKLF).
2005
-
A phase 2 clinical trial of AP23573, an mTOR inhibitor, In patients with relapsed or refractory hematologic malignancies
2005
-
A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
2005
-
A randomized, open-label study of Lestaurtinib (CEP-701), an oral FLT3 inhibitor, administered in sequence with chemotherapy in patients with relapsed AML harboring FLT3 activating mutations: Clinical response correlates with successful FLT3 inhibition.
2005
-
A report of the event free survival (EFS) for children with newly diagnosed standard risk acute lymphoblastic leukemia (ALL) treated on pediatric oncology group (POG) protocol 9605.
2005
-
A report of the event-free survival (EFS) and neurotoxicity for children with newly diagnosed standard risk acute lymphoblastic leukemia (ALL) on pediatric oncology group (POG) protocol 9405.
2005
-
Adhesive characteristics of hemoglobin SC red blood cells.
2005
-
Antigen-specific T lymphocyte function following unrelated cord blood transplantation (UCBT).
2005
-
Blocking complement-mediated hemolysis using RNA aptamers that bind complement component C8
2005
-
CD26 inhibition enhances allogeneic donor cell homing and engraftment after in utero bone marrow transplantation.
2005
-
Clinical and genetic profiles of the aging sickle cell patient.
2005
-
Combination of datmorubicin and cytarabine chemotherapy with gemtuzumab ozogamicin as initial therapy for elderly patients with previously untreated acute myeloid leukemia.
2005
-
Corticosteroids and increased risk of readmission after acute chest syndrome.
2005
-
Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV.
2005
-
Delayed wound healing in hemophilia B mice.
2005
-
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia (ALL) - Cancer and leukemia group B study 9511
2005
-
Efficacy of performing a second non-myeloablative allogenic stem cell transplant.
2005
-
Erythropoietin and erythropoietin receptor expression in early stage non-small cell lung cancer: Prognostic significance.
2005
-
Ex vivo expansion of umbilical cord blood T cells for adoptive immunotherapy.
2005
-
Gene expression patterns identify novel biologically relevant signaling and transcriptional pathways involved in terminal erythroid differentiation and polycythemia vera
2005
-
Left sided heart dysfunction in sickle cell disease: Echocardiographic and genetic studies.
2005
-
Morbidity and associated sudden death in sickle cell disease.
2005
-
Multimodal dose dense therapy for mantle cell lymphoma.
2005
-
Outcome and immune reconstitution following T cell depleted nonmyeloablative allogeneic transplantation using matched donors
2005
-
Partially HLA matched, non-myeloablative allogeneic transplantation
2005
-
Pathogenic role of surface platelet factor 4 complexes in heparin-induced thrombocytopenia: Diagnostic and therapeutic implications.
2005
-
Phase I study of gemcitabine, fludarabine and mitoxantrone for relapsed or refractory leukemia.
2005
-
Post-thaw colony forming unit (CFU) counts and yield are the most important predictors of engraftment and survival following unrelated donor cord blood transplantation (CBT): A COBLT study report.
2005
-
Priapism in SCD: Clinical and genetic correlations.
2005
-
Rapid in vivo acquisition of effector Tc1 phenotype even before myeloid engraftment predicts opportunistic infections (OI) in unrelated cord blood transplant recipients.
2005
-
Reaction of fibrinogen with homocysteine thiolactone mimics the dysfibrinogenemia produced by hyperhomocysteinemia.
2005
-
Role of LW and AKAP79 in beta-adrenergic receptor signaling-induced sickle red blood cell adhesion.
2005
-
The relationship of plasma laminin levels to anemia and the effect of soluble laminin on sickle red cell adhesion in SCD.
2005
-
Thrombotic and hemorrhagic events for patients on pediatric oncology group (POG) protocols 9201, 9605, 9406.
2005
-
Transplant outcomes and stabilization of neurological function in young children with MPS III (Sanfilippo syndrome) after unrelated donor umbilical cord blood transplantation.
2005
-
Unique reversible but serious adverse events in very young infants undergoing unrelated donor umbilical cord blood transplantation for non-malignant conditions: Increased autoimmune cytopenias and hypertrophic cardiomyopathy.
2005
-
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.
2005
-
Blocking complement-mediated hemolysis of PNH erythrocytes by RNA aptamers to C8 and C9.
2004
-
CALGB 59901: Results of a phase II study of 506U78 in CTCL and PTCL.
2004
-
CALGB 90003: Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: An intergroup phase II study
2004
-
COAT platelet formation is P2Y 12-dependent
2004
-
Campath-1H may have activity in the treatment of multiple myeloma.
2004
-
Characterization of autoantibodies to PF4/heparin in a rat model of cardiopulmonary bypass.
2004
-
Comparison of diagnostic and relapse flow cytometry phenotypes in childhood ALL: Implications for residual disease (MRD) detection
2004
-
Cord blood (CB) bank log CD34(+) and CD34(+) subsets (CD38(-)CD61(+)CD90(+)) are significantly correlated to log total CFU, CFU-GEMM, CFU-GM and BFU-E: A report from the COBLT program
2004
-
Cord blood transplantation for lysosomal storage diseases demonstrates the potential of cord blood cells for future cellular therapies
2004
-
Defibrotide (DF) for the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post SCT: Final results of a phase II, multicenter, randomized study and preliminary analyses of surrogate markers and ultrasound findings
2004
-
Dendritic and T cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation. A multivariate analysis of host, graft, and day+50 immune profile.
2004
-
Dose dense, high intensity induction therapy followed by early high dose chemotherapy (HDT) and autologous hematopoietic stem cell transplantation (AHSCT) for mantle cell lymphoma (MCL).
2004
-
Dose dense, high intensity therapy in newly diagnosed elderly patients with acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg (TM)) and high dose cytarabine (HiDAC).
2004
-
Effects of pre-analytical variables on the anti-FXa chromogenic assay when monitoring unfractionated heparin and low molecular weight heparin anticoagulation.
2004
-
Effects of single nucleotide polymorphisms of the beta(2) adrenergic receptor and of adenylate cyclase on sickle red cell adhesion to laminin
2004
-
Epinephrine-induced sickle red cell adhesion and vaso-occlusion in vivo is inhibited by the beta-adrenoceptor blocker propranolol
2004
-
Establishment of the NMDP cord blood banking network.
2004
-
Ex vivo gene therapy of a preadolescent with x-linked severe combined immunodeficiency
2004
-
FLT3 signaling is not necessary to the leukemogenic properties of MLL fusion genes in a marine model.
2004
-
Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial
2004
-
Genetic polymorphisms associated with risk for pulmonary hypertension and proteinuria in sickle cell disease.
2004
-
Hematopoietic cell transplantation for sickle cell disease: Updated results of the multicenter trial.
2004
-
Heparin-induced thrombocytopenia is a thymus (T cell) dependent disorder.
2004
-
High expression of granzymes and perforin along with increased T cell cycling in vivo predicts the development of opportunistic infections (OI) following unrelated cord blood transplantation (UCBT).
2004
-
Hypoxic vasodilation by red blood cells and impairment in vascular disorders
2004
-
Immunophenotype and analysis of allo-reactivity of umbilical cord blood (UCB)-derived T-cells following ex-vivo expansion
2004
-
Intense immunochemotherapy (IC) and autologous stem, cell transplant (ASCT) for untreated patients (pts) with mantle cell lymphoma (MCL): CALGB 59909. A preliminary report.
2004
-
Multimodal dose dense therapy for mantle cell lymphoma.
2004
-
Pharmacogenetics of minimal residual disease response in children with acute lymphoblastic leukemia (ALL).
2004
-
Phase II study of thalidomide in escalating doses for follicular (F-NHL) and small lymphocytic lymphoma (Sll): CALGB study 50002
2004
-
Point of care monitoring of the international normalized ratio in patients with antiphospholipid antibodies.
2004
-
Protein kinases associated with activation of sickle red blood cell adhesion
2004
-
Pulmonary hypertension in SS, SC and so thalassemia: Prevalence, associated clinical syndromes, and mortality.
2004
-
Recryopreserved and rethawed aliquots with anti-CD3, IL-2, IL12 significantly expands NKT cells, NKT KIR substes and NK cytotoxicity compared to short-term expansion: Potential for CB adoptive cellular immunotherapy (ACI).
2004
-
Red blood cell S-nitrosohemoglobin deficiency in pulmonary arterial hypertension
2004
-
Risk factors for intracranial hemorrhage in children with sickle cell anemia.
2004
-
Sequential topoisomerase I (topo I) and topoisomerase II (topo II) inhibitors in relapsed/refractory aggressive NHL: Results of CALGB 59906, a phase II study of doxorubicin and topotecan.
2004
-
Specialized bone marrow endothelium defines microdomains for tumor and stem cell engraftment.
2004
-
The association of an early hemoglobin response with alternative metrics to evaluate treatment efficacy of erythropoietic agents.
2004
-
The impact of anemia on mortality, cognition and function in a racially diverse community-dwelling elderly population.
2004
-
The use of DT388-IL3 fusion protein in patients with refractory acute myeloid leukemia(AML)
2004
-
Thrombocytopenia is more common and nadir occurs earlier with unfractionated heparin than with low molecular weight heparin - Results from the prospective catch registry.
2004
-
A cost-effectiveness evaluation of imatinib versus interferon-alpha plus low-dose Ara-C for first-line treatment of patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
2003
-
A novel method for ex-vivo expansion of NKCD3-/CD16+/56(+bright/dim) subjects expressing increased inhibitory receptors from cryopreserved/thawed/expanded/recryopreserved (CTECT) umbilical cord blood (UCB) using anti-CD3, IL-2, IL-7, and IL-12 (AB/CY): Implications for adoptive cellular immunotherapy (ACI) post umbilical cord blood transplantation (UCBT)
2003
-
A single cell analysis of immunoglobulin genes in chronic lymphocytic leukemia (CLL): Progressive somatic mutations in the immunoglobulin heavy and light chains contribute to intraclonal diversification in CLL.
2003
-
Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study.
2003
-
B-CAM/LU polymorphisms: Effect on sickle cell disease outcomes and cell adhesion.
2003
-
Bronchiolitis obliterans organizing pneumonia (BOOP) after bone marrow transplantation (BMT) for sickle cell disease (SCD): Association with acute chest syndrome (ACS).
2003
-
Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells.
2003
-
Chronic lymphocytic leukemia cells (CLL) express the neuronal isoform of nitric oxide synthase (NOS1), and NOS1-specific inhibitors induce CLL cell death.
2003
-
Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy from HLA matched siblings.
2003
-
Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells.
2003
-
Complement-mediated hemolysis of erythrocytes is blocked by RNA aptamers to complement components C5 and C8.
2003
-
Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.
2003
-
Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma.
2003
-
Ex vivo expansion of umbilical cord blood (UCB) derived immature and mature T cells.
2003
-
Examination of a VCAM1 polymorphism as a risk modifier for clinical outcomes in sickle cell disease.
2003
-
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.
2003
-
In vitro exposure to epinephrine causes in vivo adhesion of human sickle red blood cells to vascular endothelium in nude mice: A new model for studying vaso-occlusion.
2003
-
Incidence, characteristics, and treatment of DVT in pregnant and postpartum women from the DVT FREE registry.
2003
-
Isolation of oligodendrocyte precursors from umbilical cord blood.
2003
-
Low-dose weekly paclitaxel for relapsed or refractory aggressive non-Hodgkins lymphoma.
2003
-
One day preparative regimen for allogeneic non-myeloablative stem cell transplantation (NMSCT) using 3-5/6 HLA matched related donors.
2003
-
Outcomes of 138 adult and pediatric patients undergoing cord blood transplantation from large cord blood bank.
2003
-
Pharmacokinetics of subcutaneous alemtuzumab in a patient with myeloma.
2003
-
Phase I trial with pharmocokinetics, dosimetry, toxicity and response of anti-stromal therapy using I-131 labeled chimeric anti-tenascin therapy for lymphoma.
2003
-
Phase one evaluation of gemcitabine, fludarabine, and mitoxantrone for relapsed or refractory leukemia.
2003
-
Platelet transmission electron microscopy in genetically confirmed MYH9-related disorders.
2003
-
Platelets stimulated with convulxin plus thrombin develop platelet subpopulations with increased binding of factor VIII, factor IX, and factor X.
2003
-
Preliminary results of unrelated umbilical cord blood transplantation for Sanfilippo syndrome (MPS III).
2003
-
Protein phosphatase inhibitors as potent cytotoxic agents for B-cell CLL in vitro.
2003
-
Results of the cord blood transplantation study (COBLT) unrelated donor banking program from donor screening to characterization of banked units.
2003
-
Risk assessment for hepatic veno-occlusive disease in patients treated with gemtuzumab ozogamicin (Mylotarg (R)) with or without hematopoietic stem cell transplantation.
2003
-
Sickle RBCs form microaggregates in autologous plasma following epinephrine stimulation: A role for endogenous, soluble laminin.
2003
-
Splenectomy prior to umbilical cord blood (UCB) transplantation facilitates hematologic engraftment in pediatric and adult patients.
2003
-
Successful treatment of pure red cell aplasia (PRCA) with alemtuzumab (CAMPATH-1H).
2003
-
TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials.
2003
-
The interaction of platelets and endothelial cells modulates the procoagulant/anticoagulant balance in heparin-induced thrombocytopenia.
2003
-
The small GTPase rapl activates BCAM/LU-dependent but not alpha 4 beta l-dependent adhesion in sickle red blood cells: Evidence for divergent adhesive pathways.
2003
-
Thrombocytopenia is common among patients treated with heparin and is rarely detected and evaluated with serologic testing and hematology consultation: Preliminary findings from the CATCH registry.
2003
-
Umbilical cord blood cells engraft and differentiate in cardiac tissues after human transplantation.
2003
-
Unrelated donor umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
2003
-
cAMP-dependent activation of sickle red blood cell adhesion is associated with LW serine and tyrosine phosphorylation.
2003
-
A phase II, open-label study of CLOPAREX(TM) in adult patients with refractory or relapsed acute myelogenous leukemia
2002
-
Ability of minority patients to find donors from an ethnically diverse cord blood bank.
2002
-
Anti-CD3/IL-2/IL-7/IL-12 ex-vivo expansion of previously cryopreserved and subsequent recryopreservation of umbilical cord blood (UCB) cytotoxic T lymphocytes: A new procedure for adoptive cellular immunotherapy (ACI) post UCB transplant (T).
2002
-
B-CAM/LU mediates laminin-independent cell-cell adhesion under both static and flow conditions.
2002
-
Campath-1H, T cell depleted nonmyeloablative peripheral blood stem cell transplantation from 3-6/6 HLA matched family members.
2002
-
Chronic lymphocytic leukemia (CLL) cell CD38 expression and inducible nitric oxide synthase (NOS2) expression are associated with serum IL-4 levels.
2002
-
Clinical evaluation of retroviral vectors for corrective gene transfer of adenosine deaminase (ADA) deficiency.
2002
-
Correction of congenital immunodeficiency disease with umbilical cord blood transplantation.
2002
-
Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT).
2002
-
Donor chimerism after T-Cell depleted (TCD)-Non-Myeloablative allogeneic SCT (NST) in hemoglobinopathies.
2002
-
Donor-specific tolerance after hematopoietic reconstitution with Campath-1H treated mobilized peripheral blood cells in a sublethal preconditioning regimen.
2002
-
Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children.
2002
-
Elevated expression of numerous interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis.
2002
-
Ex vivo expansion of CB derived AC 133 progenitor cells with a polyamine copper chelator: Pre-clinical data.
2002
-
Ex vivo propagation and expansion of umbilical cord blood derived immature and mature T-cells.
2002
-
Failure of a minimally toxic non-myeloablative regimen to establish stable donor engraftment after transplantation for sickle cell anemia and beta-thalassemia.
2002
-
Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.
2002
-
GLAT (Copaxone) for treatment of steroid-refractory acute graft versus host disease.
2002
-
Gene expression profiling of AAV serotype 1-5 vectors in adult and neonatal animals using in vivo bioluminescence imaging.
2002
-
Immunological and clinical responses in patients with metastatic renal cell carcinoma to vaccination with tumor RNA transfected dendritic cells.
2002
-
Immunophenotypic and functional characterization of CD4+ CD25+ regulatory T cells as a function of aging in normal human peripheral blood and autoimmune disease.
2002
-
In vitro priming and generation of cytomegalovirus-specific T cell responses from umbilical cord blood.
2002
-
In vivo engraftment and differentiation of murine adipose derived stromal cells.
2002
-
Intracellular inositol polyphosphatides signaling via factor VIIa and factor X: The possible role of protease-activated receptor 2 and tissue factor activation.
2002
-
Modulation by epinephrine of PKA-dependent signaling pathways in sickle red blood cells induces activation of LW binding to endothelial cell alpha v beta 3 integrin.
2002
-
Morpholino antisense oligomer to integrin alpha, inhibits angiogenesis in a mouse model of retinopathy of prematurity.
2002
-
Nucleated cell count and CD34+count similar between cord blood units collected from Caucasian and non Caucasian umbilical cord blood donors.
2002
-
Patients with refractory B-CLL and T-PLL treated with alemtuzumab (Campath (R)) on a compassionate basis. A report on efficacy and safety of CAM 511 trial.
2002
-
Philadelphia-chromosome (Ph+) acute lymphoblastic leukemia (ALL) in children and adolescents: Outcome with unrelated placental cord blood (PCB) transplantation.
2002
-
Preliminary analysis of a randomized phase 2 study of the safety and efficacy of 1 vs. 2 doses of gemtuzumab ozogamicin (Mylotarg (R)) in patients with high risk myelodysplastic syndrome.
2002
-
Racial/ethnic diversity achieved in national network of cord blood banks.
2002
-
Relationship of sickle red blood cell laminin binding to disease activity.
2002
-
Three methods of T-cell depletion of HPCT products: Analysis of CD34+ cell and lymphocyte purity and recovery.
2002
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up.
2002
-
Treatment of severe systemic sclerosis with allogenic marrow transplantation.
2002
-
Unrelated umbilical cord blood (UCB) transplantation for infants with acute lymphoblastic leukemia (ALL) and rearrangements of the 11q23 chromosomal region.
2002
-
Unrelated umbilical cord blood transplant for Wiskott-Aldrich syndrome.
2002
-
Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): Impact on CNS disease.
2002
-
Within-trial resource utilization and costs of patients randomized to treatment with imatinib (STI571) versus interferon-alpha (IFN-alpha) combined with cytarabine (Ara-C) in newly diagnosed patients with chronic myeloid leukemia in chronic phase.
2002
-
Effect of hyperhomocysteinemia on protein C activation and activity in vivo.
2001
-
Enumerating functionally mature monocyte-derived dendritic cells for use in cancer immunotherapy.
2001
-
High dose factor VIIa enhances clot stability in a model of hemophilia.
2001
-
Quantitating antigen specific T cell responses in peripheral blood: A comparison of peptide MHC tetramer, ELISpot and intracellular cytokine analysis.
2001
-
Dendritic cell (DC) reconstitution after nonmyeloablative allogeneic stem cell transplants
2000
-
Dendritic cell (DC) reconstitution after non-myeloablative allogeneic stem cell transplants.
2000
-
Hyperhomocysteinemia induces alterations in fibrinogen function and fibrin clot structure in a rabbit model.
2000
-
Hyperhomocysteinemia induces monocyte tissue factor (TF) expression in vivo.
2000
-
Multiple signals are required for IL-12 production by Flt-3 ligand mobilized dendritic cells.
2000
-
Prolonged disease-free survival in patients with acute myeloid leukemia in first relapse treated with gemtuzumab ozogamicin (Mylotarg (TM), CMA-676) followed by hematopoietic stem cell transplantation.
2000
-
V beta repertoire of T lymphocytes emerging in adults after unrelated umbilical cord blood (UCB) allogeneic transplantation.
2000
-
Multilineage hematopoietic development from umbilical cord blood cells with high aldehyde dehydrogenase activity
2000
-
Activated protein C (APC) functions by inhibiting initiation of coagulation rather than by terminating a hemostatic response.
1999
-
De-encryption of cellular tissue factor is independent of its cytoplasmic domain.
1999
-
Efficacy and safety of CMA-676 in patients with AML in first relapse.
1999
-
FLT3-ligand (FLT3L) mobilization of dendritic cells (DC) in patients with metastatic colon cancer.
1999
-
Residual trisomic cells in a patient with resolving transient myeloproliferative disorder and trisomy 21 mosaicism.
1999
-
The initial rate, but not the total amount, of thrombin (IIa) generated determines fibrin clot structure in a cell-based model of coagulation.
1999
-
Tissue factor independent effect of high dose factor VIIa directly correlates with factor X levels.
1999
-
Transformation of chronic lymphocytic leukemia (CLL) to Hodgkin's disease (ZED) - A treatable entity.
1998
-
Transforming properties of the P185, P210 and P230 variants of BCR/ABL in primary mouse bone marrow.
1998
-
V beta repertoire of T lymphocytes emerging after unrelated umbilical cord blood (UCB) transplantation.
1998
-
Activated platelets provide a surface for the activation of factor XI by thrombin and factor Xa.
1997
-
Cloning and characterization of the chronic neutrophilic leukemia-associated P230 BCR/ABL oncogene.
1997
-
Co-localization of factor IX and collagen type IV in human vascular tissues.
1997
-
Competition between factors X and IX for activation by f.VIIa/tissue factor (TF): Effect on thrombin (IIa) production in a cell-based model.
1997
-
De-encryption of cellular tissue factor (TF) activity increases activation of both factors IX & X.
1997
-
Generation of autologous CD4+ T lymphocyte clones specific for precursor-B (pre-B) lymphoblasts via dendritic cell (DC) presentation
1997
-
Abnormal tyrosine phosphorylated 30 kDa protein in a patient with immunodeficiency and severe encephalopathy associated with a constitutive activation of the MAPK cascade.
1996
-
Generation of T lymphocyte clones specific for acute lymphoblastic leukemia (ALL) via dendritic cell (DC) presentation.
1996
-
High dose factor VIIa promotes thrombin generation on activated platelets in the absence of tissue factor.
1996
-
Peg-L-Asparaginase (PL-A) in advanced multiple myeloma (MM): A novel agent with therapeutic potential.
1996
-
The effect of active site-inhibited coagulation factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin treatment.
1996
-
Active site-inhibited coagulation factor VIIa blocks platelet activation, thrombin generation, and accumulation of platelet-bound factor X in a tissue factor-initiated system.
1995
-
CD5/CD8 T-cell subset depletion of bone marrow in HLA-non-identical and unrelated donor transplants compared with a comparable non-depleted control group.
1995
-
CD83 is a marker for mature dendritic cells (DC) generated from peripheral blood mononuclear cells (PBMC)
1995
-
Coagulation factor XIa enhances the binding of both zymogen and activated factor IX to stimulated human platelets.
1995
-
Comparing effects on temperature of early versus late leukodepletion in platelet transfusions.
1995
-
Ex vivo generation of antigen specific T cell populations for the treatment of infectious diseases and cancer.
1995
-
Gene-transfected leukemia vaccines in acute lymphoblastic leukemia (ALL).
1995
-
Liposome-mediated gene-transfection of human precursor-B lymphoblasts.
1995
-
FACTOR IXA AND FACTOR XA PLAY DISTINCT ROLES IN TISSUE FACTOR-DEPENDENT INITIATION OF COAGULATION
1994
-
PATHOGENESIS OF TRANSPLANT-ASSOCIATED B-CELL LYMPHOMAS DIFFERS FROM THOSE ASSOCIATED WITH AIDS
1994
-
GENE-THERAPY FOR NEONATES WITH ADA-DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS
1993
-
HEMATOPOIETIC ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) WITHOUT CYTOREDUCTION IN A CHILD WITH SEVERE COMBINED IMMUNE-DEFICIENCY (SCID)
1993